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Abstract   
Titanium-based orthopedic implants are increasingly being fabricated using additive manufacturing 
(AM) processes such as selective laser melting (SLM), direct laser deposition (DLD) and electron 
beam melting (EBM). These techniques have the potential to not only produce implants with 
properties comparable to conventionally manufactured implants, but also improve on standard 
implant models. These models can be customized for individual patients using medical data, and 
design features, such as latticing, hierarchical scaffolds or features to complement patient anatomy, 
can be added using AM to produce highly functional patient-anatomy-specific implants.  Alloying 
prospects made possible through AM allow for the production of Ti-based parts with compositions 
designed to reduce modulus and stress shielding while improving bone fixation and formation. The 
design-to-process lead time can be drastically shortened using AM and associated post-processing, 
making possible the production of tailored implants for individual patients. This review examines 
the process and product characteristics of the three major metallic AM techniques and assesses the 
potential for these in the increased global uptake of AM in orthopedic implant fabrication.  
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1. Introduction 
Orthopedic surgeries (including joint replacements) are becoming increasingly common, with more 
than 1,000,000 surgeries estimated to have occurred in the United States in 2015 alone [1]. The 
demand for orthopedic implants has increased rapidly in the past few decades due to increases in 
average life spans globally, as well as increases in physical activity among the elderly. 
Contemporary orthopedic implants, such as those seen in Figure 1., must last for decades as 
opposed to years, as well as closely approximate and support the area of replacement in terms of 
mechanical properties and responses to host biology[1–5]. The requirements for implants in different 
areas vary, for example hip vs knee implants. Thus, a general view will be taken in this manuscript.  
  
 
Figure 1 Examples of customized implants. These implants were designed using 3D Digital Imaging and 
Communications in Medicine (DICOMs) and fabricated using AM techniques. 
 
A cement-less orthopedic implant must bond well to bone in the first month following implantation, 
to ensure that complete osseointegration over the next few months occurs successfully. [3,4]. 
Osseointegration is defined as a complete linkage between bone and the implant surface, i.e. 
mechanical interlocking. Full host to implant contact is achieved by the development of anchorage 
mechanisms that can withstand natural loading. Implant and bone surface features of various sizes 
become important at different steps of the osseointegration process [6]. 
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Titanium and its alloys are used widely in orthopedic applications, as seen in Figure 1 and 2, due to 
low cytotoxicity, high mechanical strength and relative biological inertness [7–10].  Pure Ti is a non-
ferrous light metal, with a nominal density of 4.51 g/cm3 and elastic modulus of 115 GPa [11]. Ti 
undergoes an allotropic transformation at 882ºC, from a body-centered cubic (β phase) structure to 
a hexagonal close packed (α-phase) structure (below 882 ºC). The phase transformation is 
accompanied by slight atomic distortion due to the plane transformation, leading to a slight increase 
in volume when cooling through the transus temperature (882ºC) [12]. Ti is spontaneously passive, 
reacting with air or aqueous environments to form a protective oxide layer that is typically ~2-7 nm 
in thickness. This layer is well maintained at normal body pH levels, and is resistant to localized 
short-term changes in pH occurring due to infection, however, total corrosion resistance is known to 
decrease over time due to the interplay of various organic and inorganic molecules such as 
lipopolysaccharides and albumin [9,13].  
 
The elastic modulus of Ti and its common alloys are generally much higher than that of bone.  Pure 
Ti has a modulus of ~120 GPa while cortical bone has a modulus of 10-30 GPa [3]. When Ti-based 
implants are in contact with bone, this modulus mismatch results in stress shielding [3,4] – cyclic 
loading and impact forces are borne largely by the implant rather than the host bone, causing the 
resorption of this ‘unused’ bone. Stress shielding causes interfacial weakening and the formation of 
wear debris, potentially leading to the requirement for revision surgeries. The biological inertness of 
Ti-based alloys, as well as their poor wear properties and notch sensitivity compared to other 
commonly used stainless steels or cobalt-based alloys, remain as hurdles in successful implant 
osseointegration[14,15] 
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Present alloy design for orthopedic applications is moving away from Ti alloys containing toxic 
elements such as Ti-6Al-4V, and towards lower modulus Ti-based alloys. The lower modulus T- 
alloys are usually typified by the β phase Ti alloys, with important properties summarized in Table 
1.  
 
Some of the most promising alloying elements under investigation are niobium (Nb), zirconium 
(Zr), tantalum (Ta) and strontium (Sr) These are all β-stabilizing elements (allowing alloys to retain 
the high temperature BCC β phase at room temperature) with similar cytocompatibility to that of Ti 
[16–19]. To reduce this effect, Ti is commonly alloyed with elements which act as stabilizers for the β 
phase, thereby reducing the Young’s modulus of the material to closer to that of bone. Of such two-
phase alloys, Ti-6Al-4V is the most commonly used for orthopedic implants, with aluminum (Al) 
serving as an α-phase stabilizer and vanadium (V) serving as a β phase stabilizer [11]. Ti-6Al-4V has 
an allotropic transformation temperature of 990ºC and a solidus temperature of 1605ºC [11,20,21] 
Table 1. Nominal mechanical properties of common Ti-based alloys used for orthopedic implants [11,22,23] 
 
Two other strategies in reducing stress shielding and improving the osseointegration of orthopedic 
Ti implants [24] include: (1) the incorporation of porosity or texture into parts to reduce stiffness and 
Material Phase 
types 
Fabrication 
method 
Elastic 
modulus 
(GPa) 
Yield 
strength 
(MPa) 
Ultimate 
tensile strength 
(MPa) 
β transus 
temp-
erature (ºC) 
Ti-6Al-4V  α + β Casting 110 850-900 960-970 995 
Ti-13Nb-13Zr α’ + β Casting 79 900 1030 575 
Ti-6Al-7Nb α + β Casting 105 921 1024 1010 
CP Ti (grade 4) α Casting 105 692 100 950 
Bone - - 10-40 - 90-140 - 
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density (either by design or manufacturing method), and (2) the reduction of modulus mismatch 
through the development of low modulus Ti-alloys; both approaches elaborated below. 
 
Programming porosity into implant designs through scaffolding may improve the speed and 
efficacy of osseointegration [25,26]. The porosity of cortical bone (i.e. the femur) is approximately 5-
30%, while that of cancellous bone is 30-90% [27]. Non-stochastic porous scaffolding in implants 
modeled on the porosity of various size scales in living bone can act as templates for the initial 
attachment and growth of bone-forming cells. Nano-porosity is required for molecular transport, 
waste removal and cell-cell signaling, while micropores are required to allow cell migration and 
capillary formation. Full vascularization occurs on the macro scale (mm) [28,29]. Bone cell 
proliferation and differentiation are thought to be positively influenced by surface roughness, with 
an average surface roughness or groove width below 1 µm being advocated as optimal [30,31] 
although other groups have suggested that larger surface grooves of up to 50 µm width [32]  may be 
ideal. While there is no consensus on the best surface topography for osteoblastic adhesion and 
proliferation, it is agreed that the method in which the texture is achieved is as important as the 
roughness parameter itself, as this affects surface chemistry [31,33] Surface roughness or texture is to 
date achieved through post-processing techniques upon Ti and its alloys. Complex surface 
topographies with a wide range of differently sized features are necessary for successful implants 
[34,35]. These topographies support the entire process of host bone attachment and the formation of a 
strong bone-implant interface.  
 
These features can be easily investigated, trialed and produced through AM processes as the page to 
part lead-time is relatively short. There is no need for re-tooling between design iterations, and 
relatively low amount of material are required to investigate different options for part design. Other 
global features such as porosity and surface roughness can be systematically varied through 
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manipulation of the AM fabrication process.  The final implant produced for the patient through 
AM can be greatly customized in a reduced time period, with reduced costs as compared to 
conventional processes such as casting.   
 
Figure 2 Patient data in the form of computed tomography (CT) or magnetic resonance imaging (MRI) scans can 
be used to create computer aided design (CAD) models, which can then be used to print custom implants. L-R 
this figure shows the initial design of a custom implant, the pre-print manipulation of the design including 
support structures in red and the final post-processed part. 
 
Improving orthopedic implant fabrication and usage via additive manufacturing (AM) techniques 
offers distinct advantages. Conventional Ti fabrication techniques include near net casting, forging, 
and machining from wrought ingot and bars. However, as Ti has low thermal conductivity and high 
reactivity with and affinity for oxygen, this presents difficulties in machining [36,37], and so these 
methods are often unsuitable for producing implants with patient specific geometries or features.  
AM processes have already demonstrated an excellent ability to serve as alternative fabrication 
routes in a number of industries, and as of 2014 the market was estimated to be worth $4.1 billion 
[38], with Ti and its alloys used for a significant amount of additively manufactured components. 
The improved geometrical freedom of AM technologies allows for increased complexity and 
customization. The localized metal melting possible in most AM processes permits for alloying in a 
manner that bypasses liquid metal (casting) issues such as solute solubility and segregation (and 
dissimilar melting points, etc.). The alloying freedom of powder-based AM is metallurgically 
unsurpassable at present.  Further benefits of AM include low material wastage and low production 
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volumes with reduced economy of scale issues[39]. Ultimately, AM allows for the production of 
parts that were previously un-manufacturable or economically unviable through traditional routes, 
as per the three-axis model of product manufacturability seen in Figure 3.  
 
Figure 3 The three-axis model of product manufacturability shows that product design must consider 
complexity, required iterative customizability and required volume to be readily manufacturable. 
Reproduced with permission[40]  2014, Elsevier. 
 
In a holistic sense, AM may be carried out through seven major approaches; material extrusion, 
material jetting, binder jetting, vat photo-polymerization, sheet lamination, directed energy 
deposition and powder bed fusion, with the latter two used for the fabrication of strong, net shape 
metallic bone replacements [41]. Powder bed fusion techniques, such as Electron Beam Melting 
(EBM) and Selective Laser Melting (SLM) utilize either a laser or electron beam to melt and fuse 
pre-alloyed or pure powders in specified patterns. Direct Laser Deposition (DLD) differs in terms of 
powder supply - the powder is gravity fed from nozzles into the laser beam and local melt pool.  In 
this way, the powders are sintered into a melt pool on the substrate. Whilst DLD can produce near-
net shapes, these have lower tolerances and less complex internal structures than possible through 
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SLM or EBM. DLD is largely used to produce significantly larger freeform components than either 
EBM or SLM. In the context of specific implant production, patient scan data, e.g. computed 
tomography (CT), can be utilized  for customized implant designs, which can then be constructed 
through powder bed fusion or energy deposition methods [39]. This process is visualized in Figure 4. 
 
 
Figure 4 Patients who require custom implants can receive them through the combination of AM techniques and 
medical imaging. Generally, patient data (e.g. MRI or CT) is used to create the design of the part. This CAD file 
(in stereolithography format) is sliced and otherwise manipulated such that the AM machine (SLM shown here) 
can fabricate the part. Following fabrication and some minor post-processing, the custom implant can be 
delivered to the patient, with a drastically reduced lead time. 
 
Even at this stage of AM development and the commercial availability of production units, work 
remains to be completed in the full characterization and understanding of AM produced part 
properties. As with any technique, part fabrication is not as simple as inputting a design and 
fabricating with fixed settings – care must be taken with the parameters chosen for processing, as 
each can have a significant effect on the microstructure, build efficiency, and mechanical and 
implantability-related properties of the part. 
 
The aim of this review is to assess the current research and technology in the context of AM for 
orthopedic implants, particularly focusing on Ti and its alloys. The first section of this manuscript 
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examines the major AM techniques currently being used to fabricate Ti implants, as well as 
process-specific properties as related to Ti-based orthopedic implants, whilst the second and third 
parts examine pre- and post-fabrication considerations. The fourth section looks at current research 
being conducted in the area, and the final section will discuss clinical and engineering perspectives 
on the production of orthopedic implants through AM.   
 
2. Additive manufacturing techniques relevant to orthopedic implants 
The three most commonly used AM processes in medical engineering (for orthopedic applications) 
are SLM, EBM and DLD. Each process begins with the development of a 3D CAD model of the 
required implant. These models can be made using individual patient data (e.g. from MRI or CT), or 
from prior (known or standard) designs – this process of applying medical data to a design model 
can be done through commercial software such as Mimics (Materialise) and Vitrea (Vital Images) 
[42]. Once the design is complete, it may be further modified to include support structures – these 
structures act as anchors to the build plate, prevent part warpage due to residual stresses, and aid in 
heat conduction away from the part. The design can then numerically sliced into 2D layers through 
the use of software (for example, Magics (Materialise) or Netfabb (Autodesk) [42,43]. The prepared 
file is sent to the EBM, SLM or DLD machine, where the 3D part is built up through multiple layer-
wise deposition and melting stages [39,44,45]. The maximum build volume is specific for each brand 
of machine, but is generally no larger than 400*400*400mm3, specifically for SLM and EBM. 
Following fabrication, the parts are cut away from the build plate and support structures. Post-
processing procedures such as hot isostatic pressing (HIPing) and/or stress relieving are performed, 
followed by surface finishing or polishing as required [46,47]. The part is prepared for implantation 
through the application of antibacterial or osteo-inductive coatings. Following sterilization (e.g. 
through γ irradiation), the implant is ready for implantation [48]. 
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The major variables in the SLM and EBM processes are as follows; laser power, layer thickness, 
scan speed and hatch spacing  [45]. These parameters affect the amount of thermal energy supplied to 
each unit volume of material, the sum of which is termed the energy density (ED). This behavior 
can be quantified as in Equation 1 [49]. 
 
Edensity =  P𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏vscan .shatching.tlayer   (1) 
where Edensity = energy density, Plaser = beam power, vscan = scan speed,  shatching = hatch spacing, tlayer 
= layer thickness 
 
Each process produces parts with specific properties, which will be discussed in the following 
sections. It is important to note that both conventional and AM manufacturing techniques may use 
the same alloys – however the relationship between processing variables during AM fabrication on 
part properties (with respect to effects on the human body) is not yet well understood. The bulk of 
previous research has centered on short term, in vitro studies of AM produced parts. A historical 
view will be taken in the following sections.  
 
2.1 SLM  
The main components of SLM machinery, as seen in Figure 5, include a fiber laser (usually 
Ytterbium) with a beam expander and focusing lenses, a build platform, powder bunker, and 
powder rake [50]. Pre-alloyed metal powders with average particle diameter between 10 and 45 µm 
are raked over the build platform, usually pre-heated to between 100 and 200ºC, after which the 
CAD driven mirror system can direct and focus the laser beam (up to 1 kW) onto the build platform 
to melt each 2D cross-section into the powder layer. The build table drops down according to the 
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specified layer thickness, generally between 20 and 100 µm, and another even layer of powder is 
raked over the work platform. The laser then melts the next layer onto the previous layer [50]. The 
entire process takes place in a purified nitrogen or argon gas environment to prevent oxidation of 
the metal powders [24]. The final part is built up by the ‘welding’ of small overlapping regions, 
ending in the production of  a 3D part with a complex, pulsed thermal history [51].  
 
Figure 5 Schematic of SLM Equipment showing fiber laser with, build chamber, powder bunker, powder rake 
and build-in-progress, and photo of a representative SLM machine. 
 
2.1.1 SLM part properties 
SLM characteristically produces parts with complex thermal histories due to the rapid heating and 
cooling cycles as well as the steep thermal gradients produced across layers [52]. Examples of 
properties produced by various groups are collected in Table 2 and discussed in the following 
sections. The laser beam causes localized re-melting and re-cooling cycles adjacent to each scan 
track. The SLM process inherently produces a steep thermal gradient between the top and bottom 
surfaces of each layer due to heat transfer through multiple layers. This can lead to melt pool 
instability, reduction of surface energies as well as dimensional inaccuracies due to contraction on 
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cooling [24]. Localized re-melting and re-cooling cycles lead to the formation of columnar β phase 
grains, which are inclined perpendicular to the laser scanning plane [50,53]. These thermal gradients 
will cause the part to have residual thermal stresses and non-equilibrium phases [54]. Residual 
stresses must be relieved prior to usage, necessitating post-processing techniques such as stress 
relieving and/or HIP to reduce the internal stresses and increase the fatigue resistance of parts to 
that comparable with conventionally fabricated equivalents [52]. Additionally, un-melted  or partially 
melted powder particles may remain on each layer between scans, leading to the formation of 
micro-voids [55]. Specific part properties are also affected by process parameters and powder 
characteristics [56].  
 
Taking a closer view, pre-alloyed Ti-6Al-4V powders, with a liquidus temperature of 1650ºC and 
solidus temperature of 1605ºC, display a “mushy” zone within the melt pool, and the cooling rate of 
this melt pool informs the layer-wise microstructural progression [57]. Cooling rates within the melt 
pool can range between 12000 and 40000 ºC/s depending on the amount of energy supplied 
(dictated by process parameters such as laser power and scan speed) [44,58]. Ti-6Al-4V particles 
initially solidify into BCC β phase   structures, present as both columnar and equiaxed grains. 
Depending on the cooling rate, the β phase can then transform into α’ martensite (above 410ºC/s) or 
α phase. Taking a macroscopic view, part properties are also spatially dependent due to anisotropic 
heat removal and interaction of cooling gradients with the bulk un-melted powder surrounding the 
growing part. The first layer of the part will have a characteristically rough surface finish since it 
has a reduced thermal conductivity due to it being comprised of loose powder, although this will be 
further influenced by the method used to cut the part from the substrate, as well as the removal of 
support structures. This leads to the formation of an unstable melt pool, and stalactite patterns 
where the cooling melt pool sinks into the adjacent loose powder [45]. The last layer of the part will 
also have a rough surface finish due to a localized reduction in thermal insulation.  
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There is a wealth of information regarding the practical capabilities of SLM to produce Ti alloy 
parts with varying porosities; however, no consensus exists on the minimum or maximum possible 
pore sizes achievable. Minimum achievable bulk pore sizes have been variously reported as 750 µm 
[59], 500 µm [60] and 100 µm [61]. SLM part porosities of 31-43%  and 32.2 to 53.4% have been 
achieved by Basalah et al [27] and El-Hajje et al [62] respectively. Guneta et al were able to achieve 
SLM produced porosities of between 32-53%, however the pore sizes produced were between 17.0-
24.0 µm, too small for cells to penetrate into the inner pores[63].  Apart from issues with cell 
penetration, smaller pore sizes are in any case more difficult to form due to the high local laser 
power causing the formation of larger melt pools, leading to powder sputtering and pore occlusion 
[59]. Additionally, issues may arise with depowdering following part completion.  Depowdering 
refers to the process of retrieving the built part from the bulk powder surrounding it, usually 
through high pressure air blasting, vibratory processing or a combination thereof [44]. Solid parts can 
be retrieved easily, however, depowdering porous parts is complex [60,64,65], due to instances of weak 
bonding between layers and loose powder, which can trap powder particles. 
 
SLM parts typically have roughness in the micrometer range, with 2-20 µm representing an average 
range [66]. This is attributed to thermal gradients across layers, and the staircase effect [45]. Different 
roughness behavior is observed according to where in the staircase the observed region is (Figure 
6). This is due to the presence of partially melted particles remaining on free surfaces. High 
hardness is also observed due to rapid cooling characteristics and low ductility, generally reported 
as at least 20% greater than comparable EBM parts [67,68]. Hardness and porosity are interrelated 
with ED, with a higher energy input causing more complete melting and reduced porosity. The 
presence of non-equilibrium phases contributes to the higher yield strength of SLM parts as 
compared to forged parts [45].   
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Figure 6 The surface roughness of an SLM produced part can vary significantly according to the surface 
location when related to a) the printing direction and b) the interaction between sloping angle and layer 
thickness – ‘down-skin’ surfaces, or down-facing surfaces show higher surface roughness. This is referred to as 
the staircase effect. 
Reproduced with permission [45]  2007, Elsevier 
 
The major defect types in SLM produced Ti-6Al-4V parts can be classed as follows; un-melted or 
partially melted particles on surfaces, random porosity and delamination between layers [51,69,70]. 
Random porosity is generally observed in SLM parts due to the presence of trapped gases in the 
melt pool, as well as a lack of fusion defects, which occur when there is insufficient ED to 
completely melt the powders in a small region. This results in the formation of irregularly shaped 
cavities with un-melted trapped powder particles and is heavily dependent on sinter neck size as 
well as particle size [27]. These form primarily along interlayer boundaries, and act as local stress 
concentrators. Micron sized pores affect fatigue strength, while residual stresses can affect fatigue 
crack growth [52]. SLM produced parts also generally have relatively high oxygen/nitrogen contents 
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[24]. SLM produced coatings form irregularly shaped particles – the inherent eccentricity of these are 
key in the formation of porous structures [71]. 
 
As mentioned, certain process parameters have been found to affect final product characteristics, 
the most important of these being scan rate, laser intensity, and layer thickness [72,73]. Changes in 
scan rate affect microstructural features, with increased scan rates causing the formation of finer 
dendritic microstructures [74]. This can be attributed to the reduced ratio of temperature gradient to 
solidification rate, as well as the increased turbulence of melt pools [75]. Increased laser intensity 
appears to increase density and therefore reduce porosity [76,77]. The increased laser intensity, while 
creating a larger immediate melt pool, also affects previous layers, resulting in increased 
heating/cooling cycles – this allows for microstructural refinement in much the same way as 
increased scan rates.  
 
Key studies into the in vitro and in vivo behavior of SLM produced Ti-6Al-4V implants include the 
work of Hollander et al. [78], Warnke et al. [79], Mangano et al. [80], Van Bael et al. [81] and Shaoki et 
al. [82]. Hollander et al. investigated the behavior of human osteoblasts on annealed sand-blasted 
SLM produced Ti-6Al-4V over a time period of 14 days [78]. Both porous (200, 400 and 7000 um 
diameter pores) and non-porous samples were produced, and cell proliferation was found to occur 
successfully on each of these samples, with proliferation and differentiation (indicated by alkaline 
phosphatase (ALP) activity) occurring in a manner similar to that expected for wrought Ti-6Al-4V. 
Following, Warnke et al. investigated the behavior of human osteoblasts (from iliac crest cancellous 
bone) on mesh Ti-6Al-4V scaffolds over a period of 72 days [79]. In agreement with the work of 
Hollander et al. (and Van Bael et al.), this experiment showed that pore sizes smaller than 500 µm 
in diameter result in cell occlusion. This prevents further in-growth and bone regeneration [79]. Cell 
morphology on the other scaffolds was found to be star-like and well spread, with multiple 
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filipodial extensions. SLM produced Ti-6Al-4V scaffold biocompatibility was confirmed with the 
use of lactate dihydrogenase (LDH), 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide 
(MTT), 5-bromo-2- deoxyuridine (BrdU), and water-soluble tetrazolium (WST) tests. The work of 
Van Bael et al. [81] further showed that lower scaffold permeability led to increased cell attachment. 
Their work also indicated that cell differentiation is likely to be more affected by pore size (with 
smaller pores providing more stimuli) than shape. The work of Hollander et al., Warnke et al. and 
Van Bael et al. all identified one key issue in SLM implant fabrication – actual pore size was often 
significantly smaller than designed pore size, with the largest diametric variance being 300 µm. 
 
Mangano et al. produced some of the first in vivo data for SLM produced implants, by implanting a 
Ti-6Al-4V mandibular micro-implant into a human patient without complications [80]. This implant 
was acid etched with oxalic acid and maleic acid to produce a final Ra of 66.8 µm.  Retrieval and 
analysis of this implant after 2 months of healing showed evidence of bone remodeling activity, 
areas of woven bone and multiple osteocyte lacunae, with a bone-to-implant contact (BIC) 
percentage of 69.51%. Shaoki et al. compared the in vivo performance of SLM-produced Ti-6AL-
4V implants with commercially available implants in a canine model, over a period of 9 weeks [82]. 
Their SLM implant had a higher roughness than the commercial implants (Ra = 10.65 ± 2.3 µm and 
Ra = 0.33 ± 0.12) but showed no significant differences in bone-implant contact ratio or bone 
formation, indicating that SLM fabricated Ti-6Al-4V implants are competitive and have great 
potential for wide spread uptake. More long-term data is yet unavailable.  
 
2.2 EBM  
EBM is a powder bed fusion technique quite similar to SLM, with the major difference being the 
energy source, which is an electron beam as opposed to a laser beam [57,83]. This requires a high 
vacuum in the build chamber to maintain beam integrity. The powder used in EBM is pre-heated to 
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40-60% of its melting temperature through successive rapid scans by the electron beam [84]. This is 
followed by a reduced scanning rate and beam current. The chamber temperature is kept between 
650 and 700ºC. 
 
An EBM system contains a computer control/recording section and an electron beam forming and 
processing system (Figure 7). An electron gun is used to generate an electron beam (up to 3 kW), 
which is then accelerated through a focusing lens and magnetic scanning coil system [50]. Pre-
alloyed metal powders are gravity fed from cassettes and raked evenly over the build table. The 
focused electron beam is directed by the CAD model slices to selectively melt patterns into the 
powder layer. The build table is then lowered according to the layer thickness, and the process is 
repeated until the part is complete. Layer thicknesses for EBM are generally kept at 50 µm, and the 
average particle size for powders used should be between 45 and 105 µm [85].  
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Figure 7 Schematic of EBM machinery showing electron gun assembly, EB focusing lens, EB deflection lens, 
powder hoppers, powder (layer) rake, build-in-progress, and build table, with photo of representative EBM 
machine. 
 
EBM has several benefits, particularly for the fabrication of parts comprised of alloys that have a  
high chemical affinity to atmospheric gases, including Ti, this issue is bypassed in EBM, as the 
process occurs in a vacuum [86]. The background vacuum is maintained within 10-4 to 10-5 Torr, with 
a helium bleed near the build area where the vacuum is reduced to 10-2 Torr to aid cooling and 
beam scan stability [44,87]. The process is extremely energy efficient, due to the high conversion 
efficiency from electricity to electron beam energy [87]. Almost all of this energy can be absorbed by 
the material/powder. Thus, the beam will have a large penetration depth, leading to the formation of 
a high temperature melt pool [88].  
 
2.2.1 EBM part properties 
Parts produced through EBM undergo characteristic microstructural progressions [87,89]. During part 
building, the part microstructure is initially composed of primary β phase. This then transforms to α 
martensite, which decomposes into α and β phases. This characteristic progression can be seen in 
Figure 8. The β phase is composed of coarse columnar grains, and therefore EBM parts are highly 
anisotropic [90]. This occurs as a result of the beam penetration depth being greater than the layer 
thickness meaning each layer is transformed several times. The uppermost layer, i.e. the layer with 
lowest thermal insulation, is formed entirely of non-equilibrium α’ phase grains. In the bulk, 
relatively slower cooling allows the α’ phase to decompose into α and β phases, leading to closer 
modulus matching with bone than conventionally manufactured Ti-based alloys.  
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The surface features produced by EBM are often difficult to control without post processing, and 
are limited by the spatial resolution of the method [35].  Diffusion between build table substrates and 
the formed part may be observed, but this can be avoided through the use of a sacrificial support 
base [87]. Powder blow-away is a common undesirable process feature, which occurs due to 
electrostatic repulsion between beam and powder [87]. Pre-heating the powder to ~730ºC using a 
defocused beam, with currents between 28-38 mA, and a scanning rate of 146000 mm/s [91,92], can 
be done to reduce this. The small-scale sintering occurring during pre-heating can reduce the blow-
away of the powder particles. However, post-process powder entrapment still presents a problem 
[39,88].  
 
Many groups have investigated the mechanical properties and surface behavior of EBM produced 
Ti-based alloys, and information about these is collated in Table 2. and discussed here. EBM 
structures have thicker oxide layers than conventionally machined surfaces [36], with the specific 
thickness of these oxides  being dependent on location, as seen in in Figure 8. and 9. This is thought 
to be due to the presence of oxidative gas species in the vacuum chamber, and the diffusion of 
oxygen from the bulk of the component to the outer layers, resulting in net oxide growth. Oxide 
thickness is also dependent on surface – different areas of the growing part will undergo different 
cooling patterns during manufacture [21,36,91]. Upper layers undergo rapid cooling due to the absence 
of surrounding material, resulting in thinner oxide layers. In contrast, side surfaces are embedded 
between adjacent un-melted powder particles, which act as thermal insulators. The high 
temperatures partially sinter these adjacent particles and vaporize residual moisture in the powder 
bed. This causes the formation of oxides 50% thicker than those present on the upper surfaces. [91]. 
Oxide thickness is also affected by build height; larger builds allow for the release of trapped 
moisture in the chamber, leading to increased stability. The upper surface oxide layer is thus only 
formed after the temperature of the layer is insufficient to drive oxygen diffusion from the bulk to 
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the surface. Therefore, the oxide formation characteristics of EBM parts may be controlled to 
produce tunable oxide thickness gradients.  This behavior is important in designing post 
manufacturing machining and finishing processes, as these may be affected by the oxide thickness. 
The cohesion and adhesive strength of these surface oxides is inversely dependent on oxide 
thickness [44]. The oxide layer prevents corrosion while interacting with calcium ions [93,94]. 
 
Figure 8 EBM fabrication of Ti-6Al-4V displays an equiaxed to columnar transition of β-grains through the 
initial 100 layers, with alternating α/β phase evolution as build height increases. 
Reproduced with permission [89], 2015, Elsevier 
 
 
Figure 9 Surface oxide thickness relates to location (i.e. top or side) in EBM fabricated Ti-6Al-4V surfaces, and is 
related to variations in cooling rates.  
Reproduced with permission [91], 2015, Elsevier 
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The porosity of parts produced by EBM is thought to occur largely as a side effect of the ‘balling’ 
phenomenon [24,95,96]. The formation of ‘balls’ is likely due to the simultaneous reduction in surface 
energy and surface area. This leads to the generation of small cavities, which is compounded by the 
effect of ‘spattering’, wherein the initial layers of the part have low resistance to electric repulsion 
occurring under electron beam radiation [96]. This effect is similar to that of ‘powder blow-away’ 
and results in the presence of large irregular pores. Pores may also arise from the presence of 
trapped argon during atomization. As mentioned previously, this porosity may be beneficial for 
bone-forming cells, but the difficulty in removing all entrapped powder is a limiting factor, as these 
particles are likely to contribute to wear and inflammatory responses.  
 
As with SLM, parts produced by EBM are heavily influenced by process conditions and powder 
characteristics. Initial powder particle size is related to final density and surface roughness; parts 
fabricated with smaller sized particles, i.e. 25-45 µm (as opposed to the commonly used 45-105µm 
particle size range used for EBM), tend to have higher average peak to valley ratios and more un-
melted particles attached on the uppermost surface [36,97,98]. Scanning velocity and line length have 
significant effects on heat concentration and material deposition. Increased scanning velocities and 
line lengths result in less heat provided to the area. Additionally, increased beam currents affect 
material deposition and ultimately may decrease the numbers of internal cavities/pores as well as 
larger agglomerates. This can be attributed to an increased driving force for sintering particles.  
 
It is important to note that the effects of these parameters are interrelated. The ratio between beam 
current (and intensity) and scanning velocity is important in considering the final properties of the 
part [83,99]. Ideally, a low scanning velocity should be paired with a moderately high beam current to 
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produce a dense and flat part with pores at the outer layers [87]. The relation between powder size 
and surface roughness is notable and may be exploited to achieve specific topographies. Surface 
roughness provides an increased surface area and micro-texture, both of which are beneficial to cell 
adhesion.  
 
The effects of varying porosity and surface roughness of EBM Ti-6Al-4V parts on in vitro and in 
vivo properties have been investigated by a number of groups, beginning perhaps most importantly 
with the work of Ponader et al. in 2008 [100]. Their experiment examined the behavior of human 
osteoblasts on EBM Ti-6Al-4V discs with a variety of surfaces (smooth, unpolished, hatched and 
sintered) over a period of 2 weeks. Higher cell viability and proliferation was observed on surfaces 
with Ra values of 0.077 µm, i.e. the smooth samples. As discussed previously, conflicting reports 
exist on whether roughness enhances or impedes osteoblastic proliferation and development, even 
on EBM Ti-6Al-4V surfaces. Ponader et al. in this study hypothesized that the key factor in the 
interaction between surface roughness and cell behavior was the propensity of the surface to allow 
cell to cell interactions. Cells prefer to attach in deep lying concave areas, i.e. between 
peaks/grooves (as this presents a low energy input configuration). Densely spread peaks (high Rq) 
and sharp peaks make cell-cell communication difficult, reducing the amount of cell proliferation – 
good cell proliferation was found in this study on surfaces with Ra values up to 24.9 µm and 
corresponding Rq values of up to 34.6 µm. Cell differentiation as indicated by the expression of 
various osteogenic genes/proteins such as ALP and osteocalcin (OC) was also examined – these 
markers were not significantly affected by surface roughness. It may be further hypothesized that 
surface roughness may affect only certain parts of the osseointegration process. In a follow-up 
study, Ponader et al. [86] investigated differences in the bone-regenerative ability of 60% porous vs. 
compact EBM Ti-6Al-4V cranial implants in a pig model over 60 days. While the porous implants 
displayed lower initial bone-implant contact (BIC) than the compact implants, a gradual increase in 
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BIC from almost 0 to 5% in the former was seen, as compared to a gradual decrease from 
approximately 30% to 9%. Thomsen et al. examined both as-produced and machined EBM Ti-6Al-
4V femoral/tibial implants (compared with wrought Ti-6AL-4V implants) in a rabbit model and 
found between 29 and 41% BIC after 6 weeks [101]. Further in vivo work by Palmquist et al., in a 
sheep model investigating the long term biocompatibility of porous femoral and dorsal EBM Ti-
6Al-4V implants compared to machined compact specimens showed BIC values of 57% after 26 
weeks [102]. Puzzlingly, both compact and porous implants exhibited this level of BIC, despite the 
porous samples exhibiting pore sizes between 500 and 700 µm. BIC however appears to be a 
somewhat unreliable indicator of long term osseointegration, particularly in terms of extrapolation 
across models, and from animal models to human. Further work by Lv et al. [103] compared large 
and small pore sizes in scaffolds, and showed that the scaffold with smaller pore sizes, 
approximately 682±27 µm, showed greater MSC viability, reduced inflammatory cytokine release 
and increased ALP activity. This was assumed to be due to the higher surface area allowing for 
increased protein adsorption, leading to increased cell proliferation and differentiation. This 
reinforces the high BIC observed by Palmquist et al.[102] between porous implant and the host bone. 
However, it is insufficient to take two studies with different cell types as incontrovertible proof for 
the preference of bone-forming cells for smaller pores. Different pore sizes exhibit different pore 
architectures, especially as perceived by cells. Thus, both pore size and roughness are somewhat 
simplistic variables to manipulate in order to improve cell adhesion and proliferation – issues of 
topography (both nano and micro) and pore interior architecture are extremely important in 
determining cell behavior.  
 
More detailed work on the potential irritation caused by EBM TI-6Al-4V parts was conducted by 
Haslauer et al. [104], who cultured human adipose derived stem cells on a variety of EBM produced 
discs  (solid polished, solid unpolished, porous) and conventionally produced discs over a period of 
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7 days, with a particular focus on the comparative release of pro-inflammatory cytokines. The 
porous EBM discs showed the highest cell viability and proliferation, as well as the lowest release 
of pro-inflammatory cytokines (interleukin-6 and interleukin-8). Haslauer et al. concluded that 
average surface roughnesses of between 30 and 40 µm (corresponding roughly to the porous and 
solid unpolished specimens), as tested in this study, could provide an enhanced biological response 
in comparison to the roughness of classical sand-blasted and acid-etched implants, of between 3 and 
4 µm. Meanwhile, Koptyug et al. [35] in their in vitro examinations of MG63 cells  on EBM Ti-6AL-
4V samples with a surface roughness range of between 14.7±4.2 µm and 22.2±5.9 µm (achieved by 
different etching times) determined there to be no significant differences in cell spreading or ALP 
activity with respect to surface roughness. Conflicting reports may be attributed to the use of 
multiple different cell types and vastly differing time scales of analysis.  
 
2.3 DLD 
The third AM technique that shows potential for biomedical applications is DLD. It differs from 
EBM and SLM in that it is a blown powder technique rather than having a bed. It combines material 
and energy delivery through the use of gravity powder feeding, allowing the stream to meet the 
energy source, creating a moving melt pool [74,105].  As with SLM and EBM, the energy source is 
used to fuse layers together to create either full parts or repair existing surfaces through cladding-
like techniques [106].  Another key difference of DLD is the potential for using multiple powders 
within the same build. This allows for the production of bespoke alloys and compositionally graded 
parts, along with the usual range of complex and customized parts [107,108].  
 
The primary components of DLD systems (Figure 10) include the following; a laser system, powder 
delivery systems (single or multiple powder hoppers), the controlled environment glove box, and 
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the motion control system (i.e. a Computerized Numerical Control (CNC) system) [107,109,110]. As 
with the previously discussed techniques, DLD production of parts begins with a design in STL 
format, which is sliced into 2D layers. This information is sent to the laser system and powder 
delivery nozzles, causing the assembly of each layer through the scanning of multiple tracks (in a 
user defined pattern). The presence of multiple powder hoppers and streams means that the 
composition of the deposited metal can be finely controlled; each hopper may be controlled 
individually to achieve the required composition [111–113].  
 
Figure 10 Schematic of DLD machinery showing powder streams converging at the point where they meet the 
focused laser beam, causing the formation of a melt pool on the fixed substrate, with a photo of a representative 
DLD machine.  
 
The major variables in the DLD process are; laser/substrate relative velocity or scan speed (varies 
between 1-20 mm/s), laser scanning pattern, laser power (between 100 and 5000 W), laser beam 
diameter (usually maintained at 1 mm), powder feed rate (1-10 g/min), powder size range (10-100 
µm in diameter, spherical particles required), and inter-layer idle time [114,115]. Each of these, and 
combinations thereof, greatly affect the final properties of any part produced. The cooling 
rate/thermal gradient ratio (R), and the temperature gradient at the solid-liquid interface (G) are 
particularly important, as the ratio of these two parameters affects solidification and therefore 
microstructure [105], as seen in Figure 11.  Generally, equiaxed grain morphologies are produced by 
higher solidification rates, which are achieved by decreasing the ratio of G to R [105]. However, this 
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is not entirely indicative of final properties, which are also highly affected by part geometry and 
material properties.  
 
DLD begins with the initiation of a melt pool, which is then superheated, and solidified. This 
involves complex powder-specific melt pool fluid mechanics and wetting behavior, as well as 
inconsistent boundary and inter-layer heat transfer [74,116]. Current DLD process optimization 
research concentrates on the modeling of these thermal gradients and stress-forming processes as a 
function of the process parameters [74,105,117]. Comprehensive reviews of the possibilities and 
properties of DLD fabricated parts have been completed and can be read elsewhere [115,118]. 
 
Figure 11 DLD part microstructure changes according to location within the part due to changes in thermal 
conductivity and repeated heating/cooling cycles, with a) showing the top region and b) showing the bottom 
region. While both regions display Widmänstatten structures, the top region shows colonies of fine lamellae and 
large laths, while the bottom region shows comparatively thicker lamellae.  
Reproduced with permission [105], 2015, Elsevier 
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2.3.1 DLD part properties 
Current issues with this fabrication technique can be broken down into three major categories – 
complex thermal history, anisotropy and build consolidation [119], with examples of the work done 
by various groups to elucidate these given in Table 2. As with the two previous processes, DLD 
fabrication results in parts with complex thermal histories due to the layer by layer nature of the 
process. As the melt pool generally penetrates multiple layers, multiple heating and cooling cycles 
occur, causing overlapping microstructural evolution processes and eventually non-homogeneous 
microstructures. Different overlapping cooling rates will form between layers, acting as another 
source of microstructural variation. Faster cooling causes the formation of discontinuous 
allotriomorphic α precipitates at existing β grain boundaries (Widmänstatten basket weave two-
phase microstructures), while slower cooling rates cause the formation of continuous layers of 
allotriomorphic α precipitates, and coarser colony microstructures within grains [119]. Anisotropy 
results due to the preferential growth of columnar grains along the build direction, oriented with the 
001 axis [119,120]. The width of these columnar grains are affected by scan speed (decreased width) 
and incident energy (increased width) [121]. The size of α and β laths has been found to increase with 
increases in laser power, feed rate and decreases in scan speed [121,122]. Texturing arises due to 
continuous re-melting of β grain tips upon themselves.  
 
Finally, DLD part consolidation is typically incomplete due to significant porosity formed during 
fabrication (lack of fusion and internal pores). In studies of the interplay of processing conditions on 
part properties, multiple groups have found that porosity decreases with increased scan speed and 
laser power, and a high laser power combined with a low powder flow rate is required to reduce 
porosity [53,114,116,119]. Post-processing is a must for any part produced by DLD, and may include 
annealing to alter the volume fraction, size and aspect ratio of primary α laths, and HIPing, which 
closes planar pores and transforms martensite [123]. 
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It has been reported that as fabricated DLD Ti-6Al-4V parts display higher tensile yield stresses 
than cast Ti-6Al-4V but brittle failure at low strains – 0.055 in the horizontal direction and 0.012 in 
the vertical direction [46]. Certain groups have produced DLD Ti-6Al-4V parts exhibiting average 
tensile strengths from 775 to 1270 MPa, similar to or greater than wrought Ti-6Al-4V [118,123,124].  
The fatigue life of Ti-6Al-4V DLD components are generally lower than those of wrought parts due 
to process specific porosity and distinct microstructures.  
 
Current research into clarifying the process dependent properties of DLD is focused on the 
characterization of thermal gradients, localized solidification phenomena and residual stresses, with 
respect to laser power and scan rate among other input parameters [115]. Very little work to date has 
examined the in vitro or in vivo performance of DLD produced Ti-6Al-4V parts, save for the work 
by Bandyopadhyay et al. examining the behavior of porous implants in a rat model over 16 weeks 
[125]. DLD produced implants of either 25.0% or 10.7% porosity were compared to implants with 
2.8% porosity. Samples with 25% porosity displayed higher intra-pore calcium ion concentrations 
in comparison to all other samples. This was seen to peak at 6 weeks and decrease at 16 weeks, and 
was postulated to be due to ongoing bone remodeling processes causing inflow/outflow of other 
important factors. In vitro work using human-derived bone-forming cells such as human 
mesenchymal stem cells or human osteoblasts remains to be completed, as well as longer term in 
vivo work in alternate animal models. 
 
2.4 Comparisons and commonalities of major techniques 
Direct comparison of the three discussed techniques is difficult due to the range of processing 
conditions achievable for each. Process specific parameters such as scan rate, power supplied and 
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ultimate ED, as well as the interaction of these with material parameters such as powder size can 
lead to wildly different properties. However, some general comments can be made regarding the 
suitability of each technique for producing specific features.  
 
SLM has a greater potential scan rate than comparable AM techniques such as EBM  [50], and finer 
control with respect to scan rate and focus. SLM can be used to create parts with tailored porosities 
and hierarchical structures [71], or to deposit coatings onto ready-made parts. However, SLM has a 
lower energy efficiency than EBM – the laser beam can lose up to 95% of its energy due to 
reflection by metal particles within the build chamber [126]. Conflicting reports exist about the 
general surface roughness produced by EBM as opposed to SLM. The higher efficiency of EBM 
leads to a reduced amount of partially melted particles; however, this may depend on the build rate. 
In any case, EBM is generally reported to be the fastest technique, especially with respect to 
building fully dense Ti-6Al-4V parts [85]. The biocompatibility of parts produced by SLM and EBM 
was investigated by Wang et al. in dog, rabbit and guinea pig models [127], with cell attachment and 
spreading on the EBM and SLM samples shown in Figure 12.  Multiple aspects of biocompatibility 
were examined, such as cytocompatibility, hemocompatibility and dermal irritation, with no 
significant differences being observed between parts produced by either technique over 2 weeks.  
 
Parts produced through EBM generally have lower tensile strength and micro-hardness as compared 
with SLM due to differences in cooling rates[66]. In EBM, the chamber is maintained at 
temperatures between 650 and 700ºC, which, along with the aid of the vacuum, causes the relative 
cooling rate of the molten Ti alloy to be slower – SLM is carried out just above room temperature, 
and so the cooling rate is much more extreme.  
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It is well known that Ti-6Al-4V parts produced by AM techniques such as SLM, EBM and DLD 
display significantly shorter fatigue lives and fatigue strength than their wrought counterparts [128–
132].  This presents a significant obstacle in the uptake of AM for use in the fabrication of orthopedic 
implants. This performance is particularly important given that during daily functional activities, 
peak bone loading occurs at relatively low frequencies (1-3 Hz), and for multiple cycles per day [48]. 
Differences in fatigue behavior arise due to process specific defects, the major contributors being 
lack of fusion pores, general porosity and the presence of majority α phases acting as sites for crack 
initiation [129]. Lack of fusion pores and general porosity in AM parts arise due to incomplete 
particle consolidation and/or the entrapment of gases during fabrication. Defects as small as 20 µm 
in size can contribute to fatigue failure, and AM process related defects can range up to 200 µm in 
size [128]. Larger and less spherical pores are more detrimental with respect to reduced fatigue 
performance. The fatigue strength of AM parts is heavily affected by the presence of micro-sized 
pores, while the growth of fatigue cracks is affected by residual stresses [52]. Two major failure 
modes are observed in AM parts; surface fatigue crack initiation and internal fatigue crack initiation 
[129]. Surface fatigue crack initiation occurs due to porosity and lack of fusion defects while internal 
fatigue crack initiation begins at α grain boundaries.  
 
More widely, EBM parts generally display lower residual stresses immediately post fabrication due 
to the higher temperatures maintained within the build chamber during fabrication [129]. EBM 
produced parts can undergo phase decomposition during cooling within the chamber, leading to the 
formation of bimodal microstructures with fine α and β phases [128] which generally possess longer 
fatigue lives than majority α phase structures. SLM parts generally display inferior fatigue 
performance than both EBM and LENS produced parts due to higher residual stresses [98]. 
Meanwhile, LENS parts have been shown to have better lower cycle fatigue performance but poorer 
higher cycle fatigue performance than mill annealed samples [133]. However, fatigue performance 
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comparable with wrought and annealed Ti-6Al-4V has been achieved in AM parts, with the use of 
post-processing treatments such as heat and HIP treatments. Heat treatments serve to reduce the 
amount of residual stress within the parts, while HIPing consolidates parts and reduces the amount 
of internal defects. These in addition with the size reduction of α phase clusters are potent 
mechanisms for reducing the initiation of internal fatigue cracks [129].  
 
 
Figure 12 Mesenchymal stem cell seeding on wrought (w), EBM (e) and SLM (s) Ti-6Al-4V samples showing that 
cell attachment and spreading at all time points was comparable on the EBM and SLM surfaces to the wrought 
Ti-6Al-4V surfaces (indicating good biocompatibility)  
Reproduced with permission [134], 2016, PLOS ONE 
In comparison to other AM processes, DLD allows for simultaneous deposition and part forming 
due to the union of the material and energy source in the same region. Compared to SLM or EBM 
parts, DLD components display higher surface roughnesses immediately following fabrication, and 
require post-processing to reduce the microstructural inhomogeneities accumulated during 
fabrication. However, DLD has the potential to produce parts with compositional differences, due to 
the multi-nozzle capabilities. This is of interest for orthopedic implants, as compositions may be 
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varied to produce functional variations across parts, corresponding to different requirements across 
a part, for example in fracture plates.  
 
3. Pre-print considerations 
3.1 Material design 
Currently, 70-80% of orthopedic implants are fabricated from Ti alloys, such as Ti-6Al-4V [135]. 
However, certain alloying elements have been reported to cause harmful effects when leaching out 
of the implant - vanadium is linked to heavy metal toxicity, while Al has been linked to the 
increased likelihood of developing Alzheimer’s disease [136]. The current focus is towards alloys 
with bio-active elements which have greater osteo-inductive properties, as well as mechanical 
properties closer to that of bone. These alloys, when used in conjunction with AM techniques, may 
facilitate significant improvements in initial implant fixation and bone healing. Ultimately, the role 
of an orthopedic implant is to work in tandem with host bone to produce a combined structure 
which can both withstand normal physiological loads and minimize local stress shielding. To this 
end, alloying elements such as Nb, Ta, Zr, and strontium (Sr) are being widely investigated. These 
are β stabilizing elements with low modulus, high strength and high resistance to corrosion [9].  
Additionally, Zr acts as a neutral element facilitating the formation of homogeneous solid solutions 
in α/β phases [137].   
 
Low modulus β phase Ti alloys are being developed worldwide [138–141]. The β phase of Ti has a 
body centered cubic structure with high symmetry (as compared to the hexagonal close packing of α 
Ti) – this is responsible for the reduced modulus and increased wear resistance in comparison to α-
rich titanium alloys [142,143]. Investigations have been conducted into the effects of differing ratios of 
β-stabilizing alloying elements such as Nb, Zr and Ta through AM fabrication) [19,144] However, 
there is controversy over the ideal alloy composition – the amount of each element must be 
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balanced to ensure that the AM fabrication is possible, while minimizing costs and improving 
performance beyond that of conventional alloy compositions and/or conventionally fabricated parts. 
 
The current focus is towards Ti-Nb-Zr-Ta and Ti-Nb-Ta-Zr compositions, with Ti-35Nb-7Zr-5Ta 
and Ti-29Nb-13Ta-4.6Zr showing the most promise, with modulus values of ~55 GPa (20% lower 
than comparable alloys) [22]. These alloys have moduli in the range of 40-80 GPa, which, when 
compared with the modulus range of cortical bone of 10-30 GPa, presents a significant 
improvement in modulus matching[3,19,135,144,145].  
 
While these alternate alloys have significant potential benefits, it must also be noted that their use in 
AM processes is currently limited due to issues with powder formation. The majority of currently 
available pre-alloyed powders are of structural steels and alloys with long research histories. DLD 
is therefore the leading technique in the investigation of new generation β phase Ti-based alloys. 
DLD allows for the in situ formation of multiple alloy blends through changing the powder feed 
rates from various hoppers containing Nb, Zr, Ta and similar powder feedstocks. Banerjee et al. 
have pioneered the use of combinatorial approaches to the development of β phase Ti alloys for 
orthopedic implants through the use of DLD [110].  
 
3.2 Raw materials 
The single most important aspect of AM, particularly powder bed fusion methods such as SLM and 
EBM is powder morphology and size. Successful powder bed fusion requires high flowability 
powders composed of regular, spherical particles within a tight size range. [60,146]. SLM requires 
particles in the diameter size range of 10-45 µm, while EBM requires slightly coarser particles in 
the size range of 45-105 µm. 
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Powder flowability is a result of the following powder properties; density, compressibility, cohesive 
strength, electrostatic forces, surface tension and space filling characteristics [44]. Powders with 
excessively fine particle size distributions will experience high rates of electrostatic repulsion [60]. 
This will adversely affect flowability, as the static forces will cause rolling and recoating to occur 
unevenly. However, a larger average particle size reduces the driving force for sintering [27]. It is 
therefore important that the particle size distribution of the powder remains within a tight threshold.  
Particle shape is also important, as it relates to the efficacy of particle packing. This affects the 
efficiency of layer forming and therefore final part properties. Flowability is linked to shape factor, 
i.e. the shape of the particles independent of dimensions - here, the most important shape factor is 
sphericity.  
 
It is important to note that the size and shape of the powders used are contingent on the methods 
used to manufacturing. The major powder forming methods are gas atomization (GA), plasma 
atomization (PA) and the plasma rotating electrode process (PREP), as well as induction plasma 
melting. GA has been reported to produce particles with a larger mean size, while PREP produces 
more spherical particles [53,147–149]. Another method for forming powders with spherical 
morphologies is the induction plasma melting method. Smaller relative powder sizes generally lead 
to better surface resolution and appearance [32]. A visual comparison between fabrication types and 
the powder morphologies before and after printing is seen in Figure 13.  
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Figure 13 SEM images of a) virgin, b) used Arcam Ti-6Al-4V 45–106 μm powder (undocumented but <30 times), 
c) 75–106 μm and d) 45–75 μm as-received novel Ti precursor. Different processing and preparation techniques 
are thus shown to produce vastly different qualities of powder, and thus the choice of feedstock for powder-
based AM techniques is of extreme importance. 
Reproduced with permission [148], 2015, The Minerals, Metals and Materials Society 
 
Though size and shape are important, the characteristics of the specific AM process must also be 
considered. SLM produced parts have better qualities when produced with a unimodal fine particle 
size distribution, while EBM produced parts have better qualities when the initial powder has a 
bimodal size distribution [44]. This allows better packing through improved layer filling and 
densification.  
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Notably, powders used during fabrication of parts using powder bed fusion methods may be 
recovered and reused. However, the characteristics of these recovered powders are often quite 
different to their initial properties. Powder recovery usually occurs through high pressure air 
blasting, vibratory processing or a combination thereof [44]. The work of Tang et al. revealed that the 
more times Ti-6Al-4V is used in EBM, several important properties change; average particle size 
decreases and particle size distribution becomes narrower resulting in improved flowability, oxygen 
content increases due to air exposure and humidity (however this does not occur in the presence of 
helium), Al and V content decrease slightly due to vaporization in vacuum, and particle sphericity 
decreases [150]. Additionally, the amount of satellite particles and agglomerates decrease due to 
repeated sieving between fabrication cycles. Therefore Tang et al. recommend not to re-use 
powders more than 4 times without the addition of virgin powder, and powders should not be 
reused more than 16 times due to the significant amount of particle distortion and surface roughness 
[150]. This detail, i.e. the number of times the powder has been recovered prior to sample fabrication, 
is rarely reported in articles examining metallic AM processes. Going forward this is an important 
parameter to consider and report, especially given the effect of powder morphology on part 
microstructure and properties.  
 
3.3 Part design and support structures 
Part design for Ti-based orthopedic implants can be roughly split into two categories – dense 
implants with surface features, and cellular scaffolds or solids (open forms, unit cells, functionally 
graded structures) [85]. Surface features such as additional holes for bone screws or the addition of 
small surface bumps can easily be added into CAD files through programs such as Solidworks 
(Dassault Systemes), Mimics (Materialise) and Rhino (Robert McNeel & Associates), or freely 
available and online programs such as those available from Autodesk or Sketchup (Trimble 
Incorporated) [42,43]. Cellular scaffolds with interconnected pores (Figure 14) offer a range of 
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benefits in comparison to traditional dense structures, the most important of which are; the potential 
to reduce stress shielding through closer property matching to bone, and the facilitation of bone cell 
ingrowth [85,151]. Pore shape, amount and porosity gradients can be altered in the design stage to 
produce parts with specific stiffnesses and strengths (as porosity increases, stiffness and strength 
generally decrease) [85]. The minimum pore size for cellular scaffolds which can allow bone in-
growth has been stated as 50 µm, however in terms of practical application, pore sizes of 300µm are 
recommended – this ensures that cell proliferation and penetration can continue (no one pore should 
be occluded by a cell), and also ensures permeability and flow of nutrients/wastes [85,152,153]. Larger 
pore sizes are also more conducive to 3D printing processes, particularly in the depowdering stage. 
Graded scaffold structures are the most promising designs in terms of improving osseointegration, 
as these have the potential to closely mimic the complex structures found in bone[81]. The literature 
contains a wealth of studies examining novel hip and knee designs with superior osseointegrative 
abilities. Notably Melancon et al present morphological and mechanical property maps for SLM Ti-
6Al-4V, emphasizing the ability to tune stiffness to native bone while accommodating for 
manufacturing discrepancies. Arabnejad et al present a high strength, porous implant model with a 
75% reduction in modulus mismatch in comparison to solid models [154]. The testing, success and 
uptake of these various alternative implant designs depends on first achieving a complete 
understanding of the characteristics of each AM process, and the properties of parts produced by 
each process.  
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Figure 14 Map of possible cellular scaffold types in terms of form and deformation behavior. 
Reproduced with permission [85], 2017, Elsevier 
 
The practical capabilities of EBM and SLM are informed by the complexity of the design. Any 
surface at a <45º to the previous layer will require a support structure [155,156]. These structures act as 
anchors to the build plate, prevent part warpage due to residual stresses, and aid in heat conduction 
away from the part. As mentioned previously, software such as Magics (Materialise) or Simplify3D 
(Simplify3D) may be used to automate or customize the design of support structures such that they 
are easily removed from the final part, however, the surface to which the supports were attached 
will generally show higher surface roughness than the rest of the part, in the micrometer range [157–
159]. Support structures are typically built to resemble trusses, but can take many other forms, for 
example blocks, points or lines (Figure 15) [156,157]. The incorporation of teeth into the part of the 
support contacting the part can aid in removal – the spacing between teeth, the height of the teeth 
and tooth contact area can all be altered according to the specific requirements. However, often 
even the presence of support structures may be insufficient to prevent warping or to prevent the part 
from peeling off the plate due to excessively high residual stresses, particularly in Ti-based alloys. 
In such extreme cases, a part redesign may be necessary. Other strategies to reduce the amount of 
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support structures required include rotating the build orientation, as well as using algorithmic 
methods in the design phase.  Various researchers have proposed algorithms for optimizing the 
amount and location of support structures, for example the methods suggested by Frank [160] and 
more recently Strano [158], however the use of Taguchi methods show the most promise [155]. There 
is currently a gap in the literature regarding the proper design and application of support structures 
specifically for Ti-based orthopedic implants with respect to the extremely high amounts of residual 
stresses formed. Going forward, this will be extremely important in the manufacture of delicate 
parts such as customized fracture plates and screws. 
 
Figure 15 Examples of different types of support structures used for SLM and EBM parts with a) showing tooth 
characteristics and b) showing alternative support structure designs. 
Reproduced with permission [155], 2014, Elsevier 
4. Post-processing considerations 
4.1 Heat treatments 
SLM and EBM parts are both notable for the formation of non-equilibrium phases due to the rapid 
heating/cooling cycles produced during fabrication. This causes a build-up of thermal stresses and 
segregation phenomena. Heat treatments may be applied to partially alleviate the presence of these 
stresses [161]. Vrancken et al. studied the effects of heat treatments on SLM produced Ti-6Al-4V 
parts, and reported the conversion of α’ phase to a lamellar mixture of α and β phases [110]. The 
samples were heated to above 995 ºC, where large β grains formed. These decomposed into 
lamellar α and β phases on cooling. A post-treatment at 850 ºC for 2 hours followed by furnace 
cooling increased ductility to ~12% compared to 7% [161]. Transformation from columnar to 
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spherical β grains has also been observed through the application of heat treatments above 1000ºC 
[162]. The presence of β grains has been observed at treatment temperatures as low as 700ºC, 
however, overall martensitic morphology appears to be dominant until larger α plates form at higher 
temperatures [75]. An instructive comparison between the various microstructures produced by heat 
treatments can be seen in Figure 16.  
 
Figure 16 Microstructural changes can be observed according to the different post-processing heat treatment 
conditions of SLM Ti-6Al-4V, a) shows an SLM sample annealed at 600ºC, b) shows an SLM sample annealed at 
700ºC, with α plate formation, and c) shows a HIPed SLM sample. 
Reproduced with permission [75], 2013, Elsevier 
 
4.2 Surface patterning 
The ultimate goal for the surface modification of permanent Ti implant surfaces (i.e. those required 
to osseointegrate) is to improve osteoblast adhesion and differentiation, leading to increased bone 
deposition. In vivo, osteoblasts work within nano-scale topographies, with collagen fibrils and HA 
having lengths of 50 to 300 nm and widths of ~0.5 nm respectively [15].  Thus, osseointegration is 
known to be affected by surface roughness and porosity [15], although little agreement exists in the 
literature on the specifics, be it the ‘optimum’ pore size range, porosity percentage, or the average 
roughness.  
 
Osteoblast or osteoblast-like cells grown on roughened Ti surfaces (ideal pore sizes of between 100 
and 500 µm, with ideal porosity of ~60%) have been shown by some groups to present reduced 
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proliferation, enhanced differentiation and the up-regulation of genes related to bone deposition 
[15,163,164]. Conversely, other groups indicate that osteoblast proliferation is improved on smooth 
surfaces with Ra values of less than 0.5 µm [165–167]. Numerous mechanisms are thought to be in 
play, with surface roughness dictating protein absorption and subsequent intracellular signaling 
cascades, particularly those related to integrins and fibronectin [168]. Higher pore volume has been 
shown to be roughly correlated with higher Ca+ concentration within pores [125], facilitating 
osteoblast adhesion and osteogenic cell ingrowth. Further into the osseointegration process, micro-
rough surfaces have been shown to reduce osteoclast activity, thereby decreasing the resorption of 
bone. Thus, the role of roughness in osseointegration can be thought of as important to the 
remodeling process, or rather the balance of activity between bone forming and bone resorbing 
cells, with surface roughness affecting multiple processes at different time scales.    
 
Current methods used for surface texturing of Ti-based implants can generate features on the 
micrometric or nano scales, through physical, chemical, electrochemical deposition and 
biochemical methods [169], however a major consideration in the application of surface texturing is 
the effect on the fatigue and other mechanical properties of the part. Line of sight methods such as 
plasma spray coating are falling out of favor due to their inability to treat complex geometries. 
Biomimetic methods such as anodization and acid etching are most commonly used to roughen AM 
produced Ti-6Al-4V implant surfaces [170].  
 
4.3 Coatings 
4.3.1 Calcium phosphate-based coatings 
Coatings are also of great use in facilitating osteoblast interactions with (cement-less) implant 
surfaces, and are an important post-processing modification to consider in the development of AM 
implants. Calcium phosphate or hydroxyapatite (HA) containing coatings have long been shown to 
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improve future bone deposition and osseointegration through ion-exchange facilitated protein 
deposition [171,172]. Multiple methods for hydroxyapatite coating deposition have been investigated 
including plasma spraying and chemical vapor deposition, and newer biomimetic solution-based 
precipitation methods. As far back as 1993, Søballe et al. were able to show that plasma sprayed 
hydroxyapatite coatings on Ti-based implants improved bone ingrowth into implant surfaces, even 
in cases of osteopenic host bone stock (shown in a canine model) [173]. Eckardt et al. were also able 
to show an improvement in bone contact (65% HA-coated implant vs. 14.7% uncoated implant) 
with the use of HA-coatings on implants in dog models, over a longer observation period of 2 years 
[174]. The application of these coatings to AM implants is a potent strategy for improving fixation. 
 
4.3.2 Refractory ion containing coatings 
Coatings containing bio-active molecules or elements can also be used to act as stimulation for bone 
forming processes. Chief among the bio-active elements currently under investigation for their 
abilities to improve bone bonding are the refractory elements Ta, Nb, Zr and Sr.  
 
Tantalum bonds well to bone and forms an apatite-like layer in simulated bodily fluid, and is noted 
for having  high fatigue and corrosion resistance [175,176]. The 3D geometry of porous Ta is similar to 
that of trabecular bone [177]. It also has a high surface energy and wettability, increasing the 
likelihood of effective cell attachment and distribution [178]. Numerous studies have shown 
increased bone-forming behavior on Ta containing surfaces as opposed to plain Ti surfaces [177–180]. 
Balla et al. demonstrated the use of DLD to deposit a Ta coating on Ti, with significantly higher cell 
density on Ta coated Ti at all time points. After 14 days of culture, a 6-fold increase was observed 
on Ta coated Ti as opposed to uncoated Ti, accompanied by increased filipodial extension by cells 
[178]. Tantalum however has a high cost of manufacture, making it suitable only as a minor alloying 
element. It has a low laser absorption coefficient due to low electrical resistivity. This has a large 
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effect in SLM, where the shallow thermal gradient within layers will affect the melt pool 
characteristics and therefore the microstructure of the part.  
 
Niobium has also has seen use in bioactive coatings and alloys [8,71,135,181]. Elemental Nb also 
displays good wear resistance and biocompatibility. The presence of Nb has been seen to improve 
cell attachment and growth, and has a beneficial effect on cell morphology, with adhering cells 
displaying multiple extensions and spreading [71]. Zhang et al. fabricated porous Nb coating on  Ti 
substrates using SLM [71]. This coating, composed of Nb2O5 and NbO2, displayed a pore size of 15-
50 µm, with an average hardness of ~392 HV. This relatively short-term study showed that Nb 
coated Ti showed significantly higher numbers of cells after 11 days, indicating a potential 
enhancement of proliferation. Zhang et al. also noted the lower melting temperature of Nb as 
opposed to Ta (2468ºC vs. 3017ºC). However, it is also quite expensive and has a low laser 
absorption coefficient. It has not either, to date, seen wide uptake in coating applications, being 
used more frequently as an alloying element.    
 
Perhaps the most promising element for use in orthopedic implants is Sr. The presence of Sr ions as 
substitutions in HA layers has been shown to enhance bone formation and inhibit bone resorption 
[15]. Sr is an alkaline earth metal with properties like that of calcium. For this reason, it functions 
similarly to Ca in the body. Strontium acts on bone cells to control bone resorption and regulate 
genes involved in osteoblastic cell replication, differentiation and survival. More specifically, it 
inhibits osteoclasts and therefore bone resorption, and improves the differentiation and activity of 
osteoblasts [182–188]. Li et al. investigated the effects of 10% Sr substituted HA coatings on implant 
fixation in a rat model, and found that after 12 weeks, bone to implant contact increased by 49.9% 
as compared to implants coated with non-substituted HA [189]. Subsequently Yang et al. investigated 
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the effect on bone marrow mesenchymal stem cell osteogenesis of coating Ti with Sr substituted 
nano-hydroxyapatite deposited via electrochemical techniques. Sr substitution significantly 
enhanced ALP activity in bone marrow stromal cells (BMSCs) in comparison to non-substituted 
HA coatings [190].  
 
4.4 Surface finishing and sterilization 
All AM processes produce parts with relatively high surface roughnesses (>Ra 15 µm), which 
relates to the presence of semi-melted particles left on outer surfaces following fabrication. As 
discussed previously, these areas experience different cooling rates due to heat transfer from the 
melted part directly to the powder bed, and do not undergo re-melting cycles from subsequent layer 
laser penetration. This roughness has important consequences with respect to both material 
performance and biological responses (e.g. inflammation, osseointegration), and combined with the 
high notch sensitivity of Ti-6Al-4V mean that as-fabricated AM parts will generally exhibit shorter 
fatigue lives. Without surface finishing, semi-melted particles on AM Ti-6Al-4V surfaces have the 
potential to detach following implantation, and cause localized osteolysis [191]. Semi-melted 
particles have been shown to affect cell migration and reduce the effective surface area for 
integration [191,192].  However there is little data in the literature at present to quantify this with 
regards to specific processes and parameters used. Of the few studies currently published, 
Vaithilingam et al and Matsoukova et al performed in-vitro studies to investigate the potential 
cytotoxicity of particles detaching from the surface of AM Ti-6Al-4V implants and found no 
evidence of particles detaching even without post-processing [191,193]. 
 
In any case, the surface finish of AM parts is of paramount importance in post-implantation 
osseointegration. Common methods for improving the surface finish of AM parts include 
44 
 
  
 
mechanical blasting, chemical etching, laser ablation, micromachining, vibratory grinding and 
polishing [194]. These processes are generally line-of-sight dependent, and so difficulties arise in the 
appropriate finishing of intricate internal structures such as pores and lattices. Relatively few studies 
have compared processes but initial evidence suggests that sand blasting and electropolishing are 
inappropriate as the finishing media can be difficult to remove.  Specifically, sand blasted parts 
display surfaces with impregnated blast media in the form of AlOx elements – Al ions in the outer 
oxide layer of Ti-6Al-4V have been shown to reduce the oxide stability and increase the likelihood 
of Al ion dissolution [191,192]. Electropolishing and chemical etching can lead to the formation of 
micropits, increasing oxygen infiltration, as well as destabilize the native oxide layer, reducing 
corrosion resistance [191,195].  Conversely, Longhitano et al investigated the combination of various 
finishing processes on SLM Ti-6Al-4V, and found that blasting followed by chemical etching 
produced parts with and Ra of approximately 4 µm – this can be explained by the stepwise action of 
blasting removing material from the surface, and subsequent etching removing blast media from the 
surface.  
 
Surface finishing techniques such as laser ablation and milling show more promise. Mohammad et 
al investigated the use of laser ablation in reducing the surface roughness of EBM Ti-6Al-4V and 
were able to achieve a surface finish of 13 µm (Ra) with a laser fluence of 150 J/cm2 [196]. Bagehorn 
et al, compared various finishing techniques on SLM Ti-6Al-4V and found milling to produce the 
smoothest surface compared to blasting, vibratory grinding and micro-machining [130]. Additionally, 
milling improved the fatigue performance of the SLM Ti-6Al-4V to replicate that of forged Ti-6Al-
4V.  
 
It is important to note that surface finishing processes are ‘line of sight’ limited, and so intricate 
internal structures like pores or lattices are difficult to finish, much less inspect. In the same manner 
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as finishing processes are ‘line of sight’ limited, so too are sterilization methods. Commonly used 
sterilization processes for orthopedic implants, including AM, extend to ethylene oxide gas 
sterilization (exposure to ethylene oxide under vacuum), steam sterilization (exposure to high 
temperature steam) and γ radiation. Of these, γ radiation is the most favorable, as it has the potential 
to sterilize both intricate internal structures, internal voids (defects) and complex geometries 
without leaving behind sterilization products [197]. To our knowledge, no studies have examined the 
effects of sterilization on the mechanical properties of AM parts, and this remains a significant gap 
in the literature. 
 
At present, the assessment of the efficacy of finishing and sterilization processes occurs on a case 
by case basis. As the technology develops, so too do regulatory concerns and guidelines, and at 
present the Food and Drug Administration of the United States of America requires premarket 
submissions for medical devices in 3D printing to provide validation of any cleaning and 
sterilization process used [198]. The relevant regulations and guidelines are discussed further in 
Section 6.  
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5. Case studies 
Table 2. Selected AM processing parameters and properties of Ti-6Al-4V parts  
Process 
Process parameters Properties Ref 
Particle 
size 
(µm) 
Layer 
thickness 
(µm) 
Scan rate 
(mm/s) 
Laser 
power 
(W) 
Spot 
size 
(µm) 
Hatch 
spacing 
(µm) 
Young’s 
modulus 
(GPa) 
Yield 
strength 
(MPa) 
Ultimate 
tensile 
strength 
(MPa) 
Elongation 
(%) 
Vickers 
hardness 
Density/ 
porosity 
Surface 
roughness Other 
 
SLM 15-70 
(PA*) 
50 225 157 70 100 xz; 115±6 
zx;119±7 
xy; 113±5 
 
xz; 978±5 
zx; 967±10 
xy; 1075±25 
 
xz; 1143±6 
zx; 2228±3 
xy; 
1199±49 
 
xz; 118±0.5 
zx; 8.9±0.4 
xy; 7.6±0.5 
 
- - upskin – 
6.834 
sideskin – 
28.587 
(Ra in µm) 
 
 
 
 
 
[199] 
15-75 
(PA*) 
50 58 42 30 30 119±7 - - - 500 99.4±0.2% -  [200] 
5-50 
(PA*) 
30 1600 250 52 60 109±7 967±10 1117±3 8.9±0.4 - - -  [161] 
30 
(GA**) 
50 200 200 130 50 - 910±9.9 1035±29.0 3.3±0.76 - - -  
 
[98] 
15-25 
(GA**) 
 
30 
60 
90 
686 
710 
102 
175 
375 
- 12 
18 
- 1100 - - - - -  [201] 
20-50 
(GA**) 
20 800-1500 150-200 150 75 - >1 (0.2% 
proof stress) 
1200 <10 - 0.1% -   
43 
(GA**) 
30 710 175 - 150 - - - - - - -  
 
[51] 
40 
 
30 450 100 - - - 1008±30 1080±30 1.6±2% - - - mean 
fatigue life 
of 27,000 
cycles 
 
[52] 
EBM 
 
30 
(GA**) 
build 
parameters 
absent 
     1150 
 
 
1100 
1200 
 
 
1150 
25% 
 
 
16% 
3.6 
3.8 
3.6 
4.1 
  for EBM1 
(top end) 
 
for EBM2 
 
47 
 
  
 
Process 
Process parameters Properties Ref 
Particle 
size 
(µm) 
Layer 
thickness 
(µm) 
Scan rate 
(mm/s) 
Laser 
power 
(W) 
Spot 
size 
(µm) 
Hatch 
spacing 
(µm) 
Young’s 
modulus 
(GPa) 
Yield 
strength 
(MPa) 
Ultimate 
tensile 
strength 
(MPa) 
Elongation 
(%) 
Vickers 
hardness 
Density/ 
porosity 
Surface 
roughness Other 
 
 
 
1170 
 
 
1230 
 
 
12% 
 
 
380 
 
 
(top end) 
 
for 
wrought 
Ti64 
 
Table 
d45-100 
(GA**) 
70 Arcam 
standard 
60 kV Arcam 
standard 
Arcam 
standard 
180±15    425±50    [36] 
45-100 
(GA**) 
100 energy 
input per 
unit length 
= 0.55 
J/mm, line 
offset of 
1.0 mm 
   parallel loading 
= 12.9±0.9 
perpendicular 
loading 
= 3.9±2.1 
complete 
infiltration of 
osseous tissue 
parallel 
loading 
=148.4±3.5 
perpendicular 
loading 
=127.1±29.2 
   mean pore 
size = 0.45 
mm 
porosity = 
61.3%  
 
 designed 
porosity 
 
[86] 
45-105 50 arcam 
standard 
arcam 
standard 
arcam 
standard 
arcam 
standard 
 top layer 
=823.4±0.1 
bottom layer 
=851.8±5.8 
top layer 
=940.5±6.5 
bottom 
layer 
=964.5±0.3 
top layer 
=13.2±0.7 
bottom 
layer 
=16.3±0.8 
top layer 
=319±5, 
bottom layer 
=327±5 
- -  [89] 
45-105 50      10 mm 1; 
851.8±5.8 
10 mm 2; 
836.6±8.7 
10 mm 3; 
827.9±0.9 
10 mm 4; 
823.4±0.1 
10 mm 1; 
964.5±0.3 
10 mm 2; 
953.7±4.3 
10 mm 3; 
944.5±5.8 
10 mm 4; 
940.5±6.5 
10 mm 1; 
16.3±0.8 
10 mm 2; 
15.2±1.2 
10 mm 3; 
14.0±0.5 
10 mm 4; 
13.2±0.7 
     
DLD 
 
50-150 - 22.5 mm/s 200 W - -      30%   [108] 
150 
mesh 
- 635 
mm/min 
350 W - hatch 
distance of 
0.38 mm, 
with layer 
spacing of 
0.25 mm 
       single β 
phase 
formed, 
average 
grain size 
of 50 µm 
[202] 
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Process 
Process parameters Properties Ref 
Particle 
size 
(µm) 
Layer 
thickness 
(µm) 
Scan rate 
(mm/s) 
Laser 
power 
(W) 
Spot 
size 
(µm) 
Hatch 
spacing 
(µm) 
Young’s 
modulus 
(GPa) 
Yield 
strength 
(MPa) 
Ultimate 
tensile 
strength 
(MPa) 
Elongation 
(%) 
Vickers 
hardness 
Density/ 
porosity 
Surface 
roughness Other 
 
 45 30 1250 170 100 - - 1185 1293 6.23 402.81±11.31 - 35±5 - [119] 
 15-45 50 EOS 
default 
EOS 
default 
100 - 114.9 1093 1130 - - 95-99% 
dense 
11-13 - [46] 
 (GA**) 30 0.6 m/min, 
powder 
feed rate = 
1 g/min 
330 - 50 - 1005 1073 4 - - -  [133] 
 89 
(PREP†) 
 10.6 2 kW - - 111±3 938±22 1048±23 23±3      
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6. A clinical perspective   
The bulk of research into the properties of AM fabricated Ti-based parts has been from a 
metallurgical or biological perspective, using part geometries far removed from actual implant 
designs. With this research in its infancy, relatively little long-term clinical data is available, and so 
actual bench-to-bedside feasibility is poorly understood. With the advent of AM, and the increasing 
practicalities of producing tailored structures, it is important to consider how this new technique 
will be received by clinicians and their patients, particularly with regards to such aspects as 
financial viability and quality control/regulation. From the perspective of an orthopedic clinician, 
AM technologies offer three major advantages in comparison to conventional manufacturing; the 
ability to create Patient Specific Implants (PSIs) by combining 3D Digital Imaging and 
Communications in Medicine (DICOMs)  with standard implant designs, utilize these in surgical 
planning, and to produce aids for surgical education [42,45,60,203–205].  
 
PSIs in orthopedics have historically been created only for patients with rare diseases or complex 
reconstructive needs, i.e. approximately 1% of all implanted devices [39]. However, computational 
power and technology has improved significantly in the past 10 years, allowing more widespread 
uptake of AM for PSIs, particularly for patients with bone deficits as follows [206,207]; 
o Trauma in the form of extreme fractures arising from long term osteoporosis – implants can 
be designed to include ‘fixation features’ such as extra holes for bone screws. 
o Bone cancers, which accounted for 0.2% of new cancers in the U.S. in 2014, 26.9% of 
which arose in patients younger than 20 years old – standard designs can be adapted to both 
include ‘fixation features’, as above, or to compensate for areas of bone loss local to the 
implant. 
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o Congenital or developmental deformities such as spondyloses or scoliosis – implants can be 
made with reference to DICOMS to directly complement the non-standard structure of the 
patients’ bone in establishing optimal performance. 
o Osteoarthritis and other degenerative joint diseases which are expected to affect 25% of 
adults in the U.S. by 2030 - custom shaping allows for optimized bone preservation. 
o Bone infection or decay, for example through osteomyelitis or dental caries – DICOMS and 
‘fixation features’ can be combined to produce implants that support natural function.  
Atypical bone anatomy, poor bone stock and extreme iatrogenic bone loss are cases where AM can 
provide great value. Many patients requiring orthopedic implants will present with poor bone stock 
due to conditions such as osteoporosis, as well as long term steroid treatment [173]. These patients 
will have significantly lower bone turnover and remodeling activity, and thus there is a significant 
need in this sector for ‘smarter’ implant behavior [2]. These pre-existing conditions contraindicate 
the use of standard implants, as these are likely to both fit poorly and create additional problems in 
the months and years following implantation due to poor fixation (loosening, wear debris 
formation) [10,168,208].  
 
In this regard, AM has the potential to improve on classical orthopedic implant designs, which have 
to date been limited by conventional manufacturing techniques. Direct patient data (DICOMs) can 
be used to make exact copies of removed bone sections or to guide the design process in terms of 
inserting additional features likely to improve fixation [209]. Potential features to reduce stress 
shielding include; unique internal structures, latticing to maintain strength but not stiffness, surface 
texture, and graded porosity [210]. The design of reservoirs with pharmaceutical payloads (slow or 
fast release therapeutics, e.g. chemotherapeutic agents, bone growth promoters or antibiotics) is a 
popular new area [206,211]. Thirdly, AM fabrication lends itself well to producing low volumes of 
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highly complex parts – this means that pediatric implants can be sized specifically and iteratively 
for growing pre-pubescent patients, and take into account the complexities of young and 
incompletely ossified bone structures [212]. However, it must also be noted that there will be a 
compromise between added design complexity and AM fabrication feasibility – for example, pore 
diameters must exceed a critical threshold to allow for the full removal of residual particles present 
during the build process. Furthermore, a more complete understanding of the differences between 
conventional and AM fabrication in terms of safety is required before many of these advances can 
be widely applied in the clinic. 
 
On the other side of the operating table, AM proves invaluable for surgical planning. Surgeons plan 
for implantation by using multiple sources of 2D patient data (e.g. X-rays and CT images), and 
compile them to create a surgery strategy [213]. With the advent of AM, exact replicas of custom 
implants can be made (in medical grade polymers if not metals) and used to optimize the surgical 
planning process by providing a visual and tactile aid [204,205], as seen in Figure 17, or even used as a 
reference to guide the clinician during surgery. This is particularly useful in cases where fracture 
patterns are complex, or where intra-operation difficulties are expected. Further to this, patient 
specific instrumentation, e.g. small jigs with holes to guide surgical equipment during sectioning or 
screw insertion (osteotomy guides), can be made using the same process [204,205].  Despite the 
invaluable assistance provided by these aids, uptake will be significantly affected by cost. For 
example, in Australia, while AM surgery guides are widely used, the patient must pay the entire 
amount of up to AUD$2000, without any rebates from Medicare (publicly funded health care in 
Australia) [204]. Whether the significant costs incurred by relatively small populations of vulnerable 
patients for complicated surgeries, custom implants and patient specific instrumentation will be 
accounted for in health care systems is as yet uncertain.   
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Figure 17 Schematic showing the sequential process of custom implant design and printing showing A) image 
acquisition, B) image post-processing and CAD modeling, and C) 3D printing of models and custom implants 
Reproduced with permission [213], 2016, Dove Press 
 
While the uptake of AM in medicine has been growing exponentially, particularly for vulnerable 
patients, certain questions and confusions persist regarding the regulation, quality assurance, and 
intellectual property of customized AM implants. Medical devices in the U.S.A. are classified by 
the Food and Drug Administration (FDA) based on the risk of the device and/or the levels of 
control necessary to ensure safety and efficacy; Class I (exempt), Class II (pre-market notification, 
510 k pathway) or Class III (high risk, premarket approval pathway) [209,214]. Most orthopedic 
implants belong to Class III, indicating that these devices may be used in FDA-regulated clinical 
trials to collect safety and efficacy data prior to receiving approval to market [214,215]. AM techniques 
pose an interesting dilemma in terms of safety and liability; being that the fabrication technique is 
the only point of departure from approved devices, many AM implants are treated similarly to 
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conventionally manufactured implants and require only the application for and reception of patents 
with finite duration (as well as patient waivers) [216]. This simplistic consideration ignores some of 
the more pressing issues with AM, particularly in terms of the quality of the customized design, the 
effects of the build process on part properties and inter-machine variability, even discounting issues 
that could arise with design features that may impact safety and efficacy. Many simple AM medical 
devices have reached the American market through the class II pathway, which allows limited use 
of the device but no commercial marketing without subsequent rigorous testing, and limited 
numbers have been approved for emergency use [210,216]. However, data on wide-scale testing and 
comparisons between the properties of conventionally manufactured implants and AM equivalents 
is not yet available. Long-term data is required to give clinicians and patients a good basis for 
determining whether AM is likely to provide any benefits over conventional implants with regards 
to improved functionality and service life.  Beyond this, further issues arise with privacy and 
patents. Is the dissemination of patient-specific designs/models for surgical training or education an 
assault on said patient’s right to privacy? Should the design produced for a specific patient be 
treated as the intellectual property of the patient or the designer, or even that of the machine 
technician? This current lack of clarity is likely to deter the involvement of manufacturing 
companies, and may prove a challenge too burdensome for individual hospitals [217].  
 
The present excitement around focus on custom implants is perhaps overly optimistic, and obscures 
some of the more pertinent issues regarding 3D printing. While multiple miracle cases have been 
reported in the media (see [218–220]), the reality of patient-specific implants is altogether murkier. At 
present, the literature contains less than 5 systematic in vivo comparisons between AM fabricated 
implants and conventionally fabricated implants. Apart from the significant regulatory issues 
discussed previously, there will likely be significant pushback from clinicians - at present, the 
quality of conventionally manufactured implants is near perfect, and plenty of long term data is 
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available. No such easily comparable data is available for AM implants as yet. Little data is 
available on how quality is controlled, particularly outside the jurisdiction of the FDA in the U.S.A. 
Consequently, from a clinician’s perspective, certain questions must be answered prior to wider 
uptake; 
• Is it worthwhile to produce implants through AM, given that very little long-term usage data 
exists? Is the current data indicative of actual performance based on the specifics of the 
surgery, or of long-term performance?  
• How will AM change the practices of individual doctors/surgeons – will it be cheaper and/or 
comparable to conventionally-produced implants? Is it worthwhile to try new technologies, 
when the risks associated with the implementation of new technologies may be significant? 
Will willing surgeons be matched with willing patients given that current medical insurance 
policies are unlikely to cover many of the significant associated costs? 
• What quality regulation and legislation is in place, or is possible? How are reproducibility, 
quality and properties assured? Is the technology scalable to large numbers of patients? 
• Can AM implants provide added functionality, for example through longer service lives, 
increased osteogenic activity, or contain reservoirs with controlled release biologics or 
therapeutics? What design features to improve implant function are being developed? 
• What breakdown products may be produced as compared to conventionally manufactured 
implants? How will these be excreted? Is the implant likely to cause any inflammatory 
reactions?  
• What are the specific properties (wear, tensile strength, corrosion resistance), and how will 
these change over time?  
• What sterilization methods can be used?  
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7. An engineering perspective  
The International Organization for Standardization and ASTM International define additive 
manufacturing to be “the process of joining materials to make parts or objects from 3D model data, 
usually layer upon layer, as opposed to subtractive manufacturing methodologies (ISO 17296 and 
ASTM F2792) [146]. A workflow for the fabrication and implantation of customized orthopedic 
implants occurs generally as follows [146,212], noting that some aspects of the workflow below are 
under present revision;  
• Patient data is obtained via X-Ray and CT imaging, and converted into DICOMS 
• CAD software is used to join and modify the DICOMs with standard implant designs, as 
well as design any required patient specific instrumentation (with input from surgeons). 
Triangulation converts this geometry to an external closed surface, and this is converted into 
an STL file that describes to designed component to distinguish between inside/outside 
surfaces. Depending on the complexity of the implant, and the requirement for internal 
detail or free space, conversion may introduce errors such as surface non-unions or facet 
degeneration, and these can generally be repaired using CAD.  
• The file is processed prior to printing to allow for the specification of build orientation, the 
generation of support structures and the slicing of the 3D design into layers.  
• Net shape production via SLM or EBM occurs, notably process parameters such as laser 
power and scan speed must be carefully chosen to ensure that the build is successful. 
Alternatively, near net shape production may occur via DLD production. 
• Following printing, the parts may be post-processed to relieve residual stress or heat 
treatment, and if applicable may be subjected to hot isostatic pressing for densification. 
Furthermore, surface machining may be carried out to smooth, roughen or otherwise modify 
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implant surfaces, which may include the application of coatings (e.g. antimicrobial). 
Following sterilization, the implant may be inserted. Numerous copies of each implant can 
be produced to allow for sizing trials or surgical planning – these copies may be made using 
alternate AM techniques (e.g. polymer jetting) to reduce costs.  
The progression from design to implantation requires the consideration of multiple factors, 
including but not limited to patient-specific issues (atypical bone anatomy, quality of bone stock, 
age and life expectancy) and process-specific issues (intra-machine variation, dimensional 
tolerances, complexity of design features requiring significant post-processing). As discussed in the 
previous section, the regulatory legislation for this process must take into account six major aspects 
affecting implant quality; equipment, material, production, batch, part and finishing [146]. Current 
regulations are summarized in Figure 18. These can be linked successfully by good thermal 
management - sensor concepts can be used to monitor intra-process signals such as reflected laser 
light and melt pool temperature.  
 
Figure 18 Summary of the ASTM and ISO standards relevant to each stage of producing a customized implant 
through additive manufacturing. 
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Reproduced with permission [210], 2016, Elsevier 
The most important issue in successful AM implant fabrication is satisfactory design. With new 
design freedoms come unique design restrictions, discussed briefly here [146,212]. To ensure the even 
distribution of thermal energy, part cross-sections should be larger at the bottom than at the top, if 
not constant – this can be achieved through intrinsic design, or through altering build orientation. 
Sharp edges should be avoided to reduce form defects, as should enclosed pores, as post-process 
powder removal would not be possible. Finally, overhangs of more than 45º from the vertical 
should be minimized or supported, as the build-up of thermal stresses can cause the part to warp. 
 
Much research has been conducted into the optimization of AM techniques to produce highly 
effective orthopedic implants. However, significant gaps remain in the literature with respect to the 
interplay of various process parameters in the final properties of parts – scan speed, laser power and 
layer thickness are the most commonly investigated process parameters. Multiple adjacent factors 
must also be fully understood for effective implant design, fabrication and usage, including but not 
limited to; the influence of powder feed rate in DLD, oxygen pick-up in EBM, and the replication 
of bone features of multiple length scales (osteons, lamellae and collage fibers) [60,70,128]. The 
development of strategies to reduce residual stresses during fabrication is of paramount importance, 
as is the quantification of processing strategies to produce tailored porosity, surface roughness and 
bulk properties. Of particular interest is the development of weight reducing lattice structures within 
orthopedic implants, which can both reduce modulus mismatch and improve host responses. 
 
8. Summary  
Titanium and its alloys have proven to be a model material for orthopedic implants, aided by 
evident bio-inertness and low cytotoxicity; whilst readily produced by numerous AM production 
routes. Techniques such as SLM, EBM and DLD have been used widely in the research and 
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development of customized orthopedic implants, with parts produced behaving comparably to 
implants produced from wrought material. The properties of parts produced by each technique are 
variable based on the specific process parameters used, but certain generalizations can be made as 
follows – SLM has greater possible scan rates and thus cooling rates than EBM, and so SLM parts 
generally have greater fractions of α’phases as compared to EBM parts which have α lamellae and β 
phases in their microstructures. This affects their mechanical properties - parts produced by SLM 
generally have higher surface roughness, porosity and residual stress, but also higher tensile 
strength. Porosity is observed between layers in SLM parts, while at the laser turning point in EBM 
parts. The amount of porosity produced in SLM and EBM parts generally requires the application of 
hot isostatic processing post-build to closer the pores and increase the fatigue strength. SLM parts 
will have higher fracture strengths but correspondingly lower ductility than EBM parts.  The energy 
efficiency and build time minimization of EBM is better than that of SLM. DLD parts have the 
highest surface roughness and structural inhomogeneity of all three techniques, and generally 
require post-processing to reduce microstructural inhomogeneity. However, compositional gradients 
may be formed with this technique leading to the possibility of functional variation. Research into 
the optimization of process parameters (all three techniques) for orthopedic applications is as yet in 
its early stages, as the bulk of research into mechanical properties and surfaces has been from the 
perspective of aerospace and industrial applications.  
 
Further to the new possibilities offered by AM fabrication, new alloy compositions are also of great 
interest in improving orthopedic implant functionality. The continued development of lower 
modulus β-Ti alloys shows great promise in matching bone tissue. Compositions such as Ti-35Nb-
7Zr-5Ta and Ti-29Nb-13Ta-4.6Zr with moduli between 40 and 80 GPa are suited to production by 
additive manufacturing. The rate-limiting aspect of utilizing these new alloys in the AM of 
orthopedic implants is the difficulty in producing feed-stock suitable for SLM, EBM or DLD. 
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Powder production is still limited to a handful of companies worldwide. Similarly, improvements in 
computing power and software capabilities will further improve the translation of DICOMs to 
patient-specific implants and instrumentation.  
 
Many post-processing techniques have been widely investigated for the further functionalization of 
AM Ti-based orthopedic implants, including the use of heat treatment, surface patterning and the 
application of coatings. Surface modifications such as roughening through physical, chemical or 
biochemical methods, as well as coatings incorporating calcium phosphate-based ceramics or bio-
active elements such as Sr will further improve the effectiveness of Ti-based orthopedic implants.  
 
Presently, AM has the potential to improve upon conventional fabrication techniques, particularly in 
the production of low volumes of highly complex parts. This is already invaluable for vulnerable 
patients, and going forward, the increased uptake of AM orthopedic implants and PSI has the 
potential to improve patient outcomes. Considerable research has been conducted into the efficacy 
of SLM, EBM and DLD as fabrication techniques for orthopedic implants. Properties comparable to 
conventional Ti implants have been produced, however, currently all evidence as to efficacy is in its 
infancy – long term performance has not yet been studied extensively. As the understanding of 
these techniques develops, further tailoring and customization for specific types of implants can be 
implemented. This is the current state of the field, and significant advances are expected in the next 
ten years.  
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Figures and Captions 
 
Figure 1 Examples of customized implants. These implants were designed using 3D Digital 
Imaging and Communications in Medicine (DICOMs) and fabricated using AM techniques. 
 
Figure 2 Patient data in the form of computed tomography (CT) scans or magnetic resonance 
imaging (MRI) scans can be used to create computer aided design (CAD) models, which can then 
be used to print custom implants. L-R this figure shows the initial design of a custom implant, the 
pre-print manipulation of the design including support structures in red and the final post-processed 
part. 
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Figure 3 The three-axis model of product manufacturability shows that product design must 
address complexity, required iterative customizability and required volume to be readily 
manufacturable. 
Reproduced with permission[40]  2014, Elsevier. 
 
Figure 4 Patients who require custom implants can receive them through the combination of AM 
techniques and medical imaging. Generally, patient data (e.g. MRI or CT scans) is used to create the 
design of the part, this CAD file (in stereolithography format) is then sliced and otherwise 
manipulated such that the AM machine (SLM shown here) can fabricate the part. Following 
fabrication and some minor post-processing, the custom implant can be delivered to the patient, 
with a drastically reduced lead time. 
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Figure 5 Schematic of SLM Equipment showing fiber laser with, build chamber, powder bunker, 
powder rake and build-in-progress, and photo of a representative SLM machine. 
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Figure 6 The surface roughness of an SLM produced part can vary significantly according to the 
surface location when related to a) the printing direction and b) the interaction between sloping 
angle and layer thickness – ‘down-skin’ surfaces, or down-facing surfaces show higher surface 
roughness. This is referred to as the staircase effect. 
Reproduced with permission [45]  2007, Elsevier 
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Figure 7 Schematic of EBM machinery showing electron gun assembly, EB focusing lens, EB 
deflection lens, powder hoppers, powder (layer) rake, build-in-progress, and build table, with photo 
of representative EBM machine. 
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Figure 8 EBM fabrication of Ti-6Al-4V displays an equiaxed to columnar transition of β-grains 
through the initial 100 layers, with alternating α/β phase evolution as build height increases. 
Reproduced with permission [89], 2015, Elsevier 
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Figure 9 Surface oxide thickness relates to location (i.e. top or side) in EBM fabricated Ti-6Al-4V 
surfaces, and is related to variations in cooling rates. 
Reproduced with permission [91], 2015, Elsevier 
 
 
Figure 10 Schematic of DLD machinery showing powder streams converging at the point where 
they meet the  focused laser beam, causing the formation of a melt pool on the fixed substrate, with 
a photo of a representative DLD machine. 
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Figure 11 DLD part microstructure changes according to location within the part due to changes in 
thermal conductivity and repeated heating/cooling cycles, with a) showing the top region and b) 
showing the bottom region. While both regions display Widmänstatten structures, the top region 
shows colonies of fine lamellae and large laths, while the bottom region shows comparatively 
thicker lamellae. 
Reproduced with permission [105], 2015, Elsevier 
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Figure 12 Mesenchymal stem cell seeding on wrought (w), EBM (e) and SLM (s) Ti-6Al-4V 
samples showing that cell attachment and spreading at all time points was comparable on the EBM 
and SLM surfaces to the wrought Ti-6Al-4V surfaces (indicating good biocompatibility) 
Reproduced with permission [134], 2016, PLOS ONE 
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Figure 13  SEM images of a) virgin, b) used Arcam Ti-6Al-4V 45–106 μm powder (undocumented 
but <30 times), c) 75–106 μm and d) 45–75 μm as-received novel Ti precursor. Different processing 
and preparation techniques are thus shown to produce vastly different qualities of powder, and thus 
the choice of feedstock for powder-based AM techniques is of extreme importance. 
Reproduced with permission [148], 2015, The Minerals, Metals and Materials Society 
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Figure 14 Map of possible cellular scaffold types in terms of form and deformation behavior. 
Reproduced with permission [85], 2017, Elsevier 
 
Figure 15 Examples of different types of support structures used for SLM and EBM parts with a) 
showing tooth characteristics and b) showing alternative support structure designs. 
Reproduced with permission [155], 2014, Elsevier 
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Figure 16 Microstructural changes can be observed according to the different post-processing heat 
treatment conditions of SLM Ti-6Al-4V, a) shows an SLM sample annealed at 600ºC, b) shows an 
SLM sample annealed at 700ºC, with α plate formation, and c) shows a HIPed SLM sample. 
Reproduced with permission [75], 2013, Elsevier 
 
Figure 17 Schematic showing the sequential process of custom implant design and printing 
showing A) image acquisition, B) image post-processing and CAD modeling, and C) 3D printing of 
models and custom implants 
Reproduced with permission [213], 2016, Dove Press 
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Figure 18 Summary of the ASTM and ISO standards relevant to each stage of producing a 
customized implant through additive manufacturing. 
Reproduced with permission [210], 2016, Elsevier 
 
 
 
  
83 
 
  
 
 
Table 1. Nominal mechanical properties of common Ti-based alloys used for orthopedic 
implants [14, 19,20] 
 
 
 
 
 
 
 
 
 
Material Phase 
types 
Fabrication 
method 
Elastic 
modulus 
(GPa) 
Yield 
strength 
(MPa) 
Ultimate 
tensile strength 
(MPa) 
β transus 
temp-
erature (ºC) 
Ti-6Al-4V  α + β Casting 110 850-900 960-970 995 
Ti-13Nb-13Zr α’ + β Casting 79 900 1030 575 
Ti-6Al-7Nb α + β Casting 105 921 1024 1010 
CP Ti (grade 4) α Casting 105 692 100 950 
Bone - - 10-40 - 90-140 - 
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Table 2. Selected AM processing parameters and properties of Ti-6Al-4V parts 
(N.B. as this table is quite complex, formatting has not been changed to AHM requirements.)  
Process 
Process parameters Properties Ref 
Particle 
size 
(µm) 
Layer 
thickness 
(µm) 
Scan rate 
(mm/s) 
Laser 
power 
(W) 
Spot 
size 
(µm) 
Hatch 
spacing 
(µm) 
Young’s 
modulus 
(GPa) 
Yield 
strength 
(MPa) 
Ultimate 
tensile 
strength 
(MPa) 
Elongation 
(%) 
Vickers 
hardness 
Density/ 
porosity 
Surface 
roughness Other 
 
SLM 15-70 
(PA*) 
50 225 157 70 100 xz; 115±6 
zx;119±7 
xy; 113±5 
 
xz; 978±5 
zx; 967±10 
xy; 1075±25 
 
xz; 1143±6 
zx; 2228±3 
xy; 
1199±49 
 
xz; 118±0.5 
zx; 8.9±0.4 
xy; 7.6±0.5 
 
- - upskin – 
6.834 
sideskin – 
28.587 
(Ra in µm) 
 
 
 
 
 
[199] 
15-75 
(PA*) 
50 58 42 30 30 119±7 - - - 500 99.4±0.2% -  [200] 
5-50 
(PA*) 
30 1600 250 52 60 109±7 967±10 1117±3 8.9±0.4 - - -  [161] 
30 
(GA**) 
50 200 200 130 50 - 910±9.9 1035±29.0 3.3±0.76 - - -  
 
[98] 
15-25 
(GA**) 
 
30 
60 
90 
686 
710 
102 
175 
375 
- 12 
18 
- 1100 - - - - -  [201] 
20-50 
(GA**) 
20 800-1500 150-200 150 75 - >1 (0.2% 
proof stress) 
1200 <10 - 0.1% -   
43 
(GA**) 
30 710 175 - 150 - - - - - - -  
 
[51] 
40 
 
30 450 100 - - - 1008±30 1080±30 1.6±2% - - - mean 
fatigue life 
of 27,000 
cycles 
 
[52] 
EBM 
 
30 
(GA**) 
build 
parameters 
absent 
     1150 
 
 
1100 
 
 
1170 
1200 
 
 
1150 
 
 
1230 
25% 
 
 
16% 
 
 
12% 
3.6 
3.8 
3.6 
4.1 
 
 
380 
  for EBM1 
(top end) 
 
for EBM2 
(top end) 
 
for 
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Process 
Process parameters Properties Ref 
Particle 
size 
(µm) 
Layer 
thickness 
(µm) 
Scan rate 
(mm/s) 
Laser 
power 
(W) 
Spot 
size 
(µm) 
Hatch 
spacing 
(µm) 
Young’s 
modulus 
(GPa) 
Yield 
strength 
(MPa) 
Ultimate 
tensile 
strength 
(MPa) 
Elongation 
(%) 
Vickers 
hardness 
Density/ 
porosity 
Surface 
roughness Other 
 
 
 
wrought 
Ti64 
 
Table 
d45-100 
(GA**) 
70 Arcam 
standard 
60 kV Arcam 
standard 
Arcam 
standard 
180±15    425±50    [36] 
45-100 
(GA**) 
100 energy 
input per 
unit length 
= 0.55 
J/mm, line 
offset of 
1.0 mm 
   parallel loading 
= 12.9±0.9 
perpendicular 
loading 
= 3.9±2.1 
complete 
infiltration of 
osseous tissue 
parallel 
loading 
=148.4±3.5 
perpendicular 
loading 
=127.1±29.2 
   mean pore 
size = 0.45 
mm 
porosity = 
61.3%  
 
 designed 
porosity 
 
[86] 
45-105 50 arcam 
standard 
arcam 
standard 
arcam 
standard 
arcam 
standard 
 top layer 
=823.4±0.1 
bottom layer 
=851.8±5.8 
top layer 
=940.5±6.5 
bottom 
layer 
=964.5±0.3 
top layer 
=13.2±0.7 
bottom 
layer 
=16.3±0.8 
top layer 
=319±5, 
bottom layer 
=327±5 
- -  [89] 
45-105 50      10 mm 1; 
851.8±5.8 
10 mm 2; 
836.6±8.7 
10 mm 3; 
827.9±0.9 
10 mm 4; 
823.4±0.1 
10 mm 1; 
964.5±0.3 
10 mm 2; 
953.7±4.3 
10 mm 3; 
944.5±5.8 
10 mm 4; 
940.5±6.5 
10 mm 1; 
16.3±0.8 
10 mm 2; 
15.2±1.2 
10 mm 3; 
14.0±0.5 
10 mm 4; 
13.2±0.7 
     
DLD 
 
50-150 - 22.5 mm/s 200 W - -      30%   [108] 
150 
mesh 
- 635 
mm/min 
350 W - hatch 
distance of 
0.38 mm, 
with layer 
spacing of 
0.25 mm 
       single β 
phase 
formed, 
average 
grain size 
of 50 µm 
[202] 
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Process 
Process parameters Properties Ref 
Particle 
size 
(µm) 
Layer 
thickness 
(µm) 
Scan rate 
(mm/s) 
Laser 
power 
(W) 
Spot 
size 
(µm) 
Hatch 
spacing 
(µm) 
Young’s 
modulus 
(GPa) 
Yield 
strength 
(MPa) 
Ultimate 
tensile 
strength 
(MPa) 
Elongation 
(%) 
Vickers 
hardness 
Density/ 
porosity 
Surface 
roughness Other 
 
 45 30 1250 170 100 - - 1185 1293 6.23 402.81±11.31 - 35±5 - [119] 
 15-45 50 EOS 
default 
EOS 
default 
100 - 114.9 1093 1130 - - 95-99% 
dense 
11-13 - [46] 
 (GA**) 30 0.6 m/min, 
powder 
feed rate = 
1 g/min 
330 - 50 - 1005 1073 4 - - -  [133] 
 89 
(PREP†) 
 10.6 2 kW - - 111±3 938±22 1048±23 23±3      
* Plasma atomized particles 
** Gas atomized particles 
† Plasma rotating electrode process used to prepare particles 
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